<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>COVID-19: Clinical manifestations and diagnosis in children</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">COVID-19: Clinical manifestations and diagnosis in children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">COVID-19: Clinical manifestations and diagnosis in children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jaime G Deville, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eunkyung Song, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Christopher P Ouellette, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3084790875"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Starting in late 2019, a novel coronavirus rapidly spread throughout the world, resulting in a global pandemic. The virus was designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the illness it caused coronavirus disease 2019 (COVID-19). The clinical spectrum of COVID-19 ranges from asymptomatic infection to mild respiratory tract symptoms to severe pneumonia with acute respiratory distress syndrome and multiorgan dysfunction.</p><p>Understanding of COVID-19 is evolving. The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fpublications%2Fi%2Fitem%2FWHO-2019-nCoV-clinical-2021-2&amp;token=mr3MkQMxxRm373pPGLTYB%2B8L7rJeOJtqYOfpSLq18h7uTgB8glbKNm0sPo4%2B8z2sxDDRq3RsxdDePKvJAZemGlr4SIch0ubsJXu0hRi5XFo%3D&amp;TOPIC_ID=127488" target="_blank">World Health Organization</a>, the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-nCoV%2Fhcp%2Findex.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLETVYV9fJcW0p5%2FSZ3txP%2BHM5kLLHknys0%2FgSZyXivAUDtgQTTNyLN5lgxmxNs%2B4jK8AtSQsFLDSFqHlsS1NKKs%3D&amp;TOPIC_ID=127488" target="_blank">United States Centers for Disease Control and Prevention</a>, the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.aap.org%2Fen%2Fpages%2F2019-novel-coronavirus-covid-19-infections%2F&amp;token=Rk4xBkzE1SGKS%2Ff2rhl9kQmuTkA5VPYaYYgW%2BkL8Vtaoio6E54z5hw7UfvwH3kkfQcoU19a4ked5Vtez8asrRyoIjN8BVzblDISl2B9kdmQ%3D&amp;TOPIC_ID=127488" target="_blank">American Academy of Pediatrics</a>, and other expert groups provide ongoing guidance for evaluation, management, and prevention. Links to these and other related society guidelines are provided separately. (See <a class="local">'Society guideline links'</a> below.)</p><p>This topic will discuss aspects of COVID-19 epidemiology and clinical manifestations of acute COVID-19 infection that are specific to children. The management and prevention of COVID-19 in children, multisystem inflammatory syndrome in children, and COVID-19 in pregnancy are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/128389.html" rel="external">"COVID-19: Management in children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/129614.html" rel="external">"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) management and outcome"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/127535.html" rel="external">"COVID-19: Overview of pregnancy issues"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/134827.html" rel="external">"COVID-19: Antepartum care of pregnant patients with symptomatic infection"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/129846.html" rel="external">"COVID-19: Intrapartum and postpartum issues"</a>.)</p><p></p><p>In addition, please refer to our <a class="external" href="/landing/covid19?search=covid 19" target="_blank">COVID-19 homepage</a> to view the complete list of UpToDate COVID-19 topics.</p><p class="headingAnchor" id="H4155540577"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The epidemiology of COVID-19 is discussed in detail separately. This section focuses on the epidemiology of COVID-19 in children. (See  <a class="medical medical_review" href="/z/d/html/126981.html" rel="external">"COVID-19: Epidemiology, virology, and prevention", section on 'Epidemiology'</a>.)</p><p class="headingAnchor" id="H796342800"><span class="h2">Transmission</span><span class="headingEndMark"> — </span>Transmission of SARS-CoV-2 is discussed in detail separately. This section focuses on transmission to children and by children. (See  <a class="medical medical_review" href="/z/d/html/126981.html" rel="external">"COVID-19: Epidemiology, virology, and prevention", section on 'Transmission'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission to children</strong> – In case series early in the pandemic, most cases in children resulted from household exposure, usually with an adult as the index patient [<a href="#rid1">1-7</a>]. These findings must be interpreted with caution because the cases were identified after implementation of strict physical distancing measures (eg, school closure), limiting the exposure of children to close contacts outside their household [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1">In observational studies of household transmission before the emergence of more transmissible variants, the secondary attack rate among pediatric contacts (&lt;18 years of age) ranged from 4 to 57 percent [<a href="#rid9">9-14</a>]. In a meta-analysis of 87 studies of household transmission including 1,249,163 household contacts from multiple countries, the secondary attack rate was 18 percent among pediatric contacts (age &lt;18 years) and 30 percent among adult contacts [<a href="#rid15">15</a>]. Household transmission rates are increased with more transmissible variants [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1">Health care-associated outbreaks and cases of possible transmission from teachers or school staff to students and among students in the school setting have also been reported [<a href="#rid17">17-21</a>]. The risk is greater for individuals who are unvaccinated [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1">In utero and peripartum transmission and transmission through breast milk or during infant feeding are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/127535.html" rel="external">"COVID-19: Overview of pregnancy issues"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission by children</strong> – Although SARS-CoV-2 virus shedding varies from person to person [<a href="#rid23">23</a>], infected children appear to shed SARS-CoV-2 virus with nasopharyngeal viral loads comparable to or higher than those in adults [<a href="#rid24">24-27</a>], and children of all ages can transmit SARS-CoV-2 to others in household, child care, educational, and community settings [<a href="#rid28">28-33</a>]. Transmission may occur whether or not the child has symptoms [<a href="#rid34">34-36</a>]. Asymptomatic transmission by adults is well documented. (See  <a class="medical medical_review" href="/z/d/html/126981.html" rel="external">"COVID-19: Epidemiology, virology, and prevention", section on 'Viral shedding and period of infectiousness'</a>.)</p><p></p><p class="bulletIndent1">The relative transmissibility of SARS-CoV-2 by children in various age groups is uncertain, given the differing contributions of biologic, host, and environmental factors (eg, community transmission, ventilation, class size) [<a href="#rid28">28,37-39</a>].</p><p></p><p class="bulletIndent1">Household contact studies have identified variable rates of transmission from pediatric index cases [<a href="#rid13">13,31,34,40-44</a>]. The variable rates may be related to different community prevalence and mitigation measures, age, history of past infection, methods of diagnosing secondary cases, timing of sample collection, predominant variants, and levels of adherence to infection control measures in the home, which is particularly challenging when the index patient is a young child [<a href="#rid45">45-48</a>].</p><p></p><p class="bulletIndent1">Although transmission can occur in child care and educational settings [<a href="#rid29">29,33,49</a>], studies performed before COVID-19 vaccines were authorized for children &lt;16 years and before emergence of more transmissible variants suggested that transmission by children and adolescents in the school setting was uncommon when there was strict adherence to multiple public health measures (eg, vaccination of eligible teachers, staff, and students; isolation/quarantine; case-contact testing; improved ventilation; cohorting; physical distancing) [<a href="#rid21">21,34,49-55</a>].</p><p></p><p class="bulletIndent1">In the United States and other countries, resumption of in-person primary and secondary education before the emergence of more transmissible variants was associated with relatively few reports of school outbreaks when public health measures were followed [<a href="#rid51">51-53,56-67</a>].</p><p></p><p class="headingAnchor" id="H3964662040"><span class="h2">Number of cases and seroprevalence</span><span class="headingEndMark"> — </span>Children of all ages can get COVID-19 [<a href="#rid68">68</a>]. More than 16 million laboratory-confirmed cases of SARS-CoV-2 in children &lt;18 years of age have been reported to the Centers for Disease Control and Prevention [<a href="#rid69">69</a>]. However, this is likely an underestimation given the number of cases that are asymptomatic or not reported (eg, following a home test) [<a href="#rid70">70,71</a>]. The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.aap.org%2Fen%2Fpages%2F2019-novel-coronavirus-covid-19-infections%2Fchildren-and-covid-19-state-level-data-report%2F&amp;token=oEuriqgiYmTkwak0jzw7%2BC2QltCIiTzXKSrDKNK2QVxdxBgvkXXkJv0Eo93A8PM0b8zZc0ZqEBYDzL6lyZ2MSmvU0sMPFzcVALFMMRUahwuwDVNE4h97b%2BgZhQ9j6bfuAZNyDYqLwLigJKb3mjLmjQ%3D%3D&amp;TOPIC_ID=127488" target="_blank">American Academy of Pediatrics</a> provides information about the number of cases in children in individual states [<a href="#rid72">72</a>].</p><p>As of December 11, 2022, the seroprevalence estimate for children (6 months to 17 years) was 96.3 percent (95% CI 95.9-96.6%) [<a href="#rid73">73</a>]; many seroconversions occurred after December 2021 (concurrent with the predominance of the Omicron variant). Seroprevalence increased with increasing age: 0 to 4 years: 89.9 percent; 5 to 11 years: 97.1 percent; 12 to 17 years: 98.9 percent. Seroprevalence does not necessarily correlate with protection against reinfection, severe outcomes, or SARS-CoV-2-related complications.</p><p class="headingAnchor" id="H2252933217"><span class="h2">Hospitalization and death</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hospitalization</strong> – In population-based surveillance, the annual COVID-19-associated hospitalization rate among children &lt;18 years of age in the United States is 48.2 per 100,000 overall but varies with age (66.8 per 100,000 children age 0 to 4 years, 25 per 100,000 children age 5 to 11 years, and 59.9 per 100,000 children age 12 to 17 years) [<a href="#rid74">74</a>]. For children age 12 to 17 years, the COVID-19-associated hospitalization rate is greater than that for influenza during the three years before the COVID-19 pandemic; for children &lt;12 years, the COVID-19-associated hospitalization rate is similar to or lower than that for influenza.</p><p></p><p class="bulletIndent1">Weekly COVID-19 hospitalization rates in children and adolescents have varied throughout the pandemic. They peaked initially in January 2021 (1.5 per 100,000 population), again in September 2021 with predominance of the Delta (B.1.617.2) variant (1.8 per 100,000 population), and then again in January 2022 with predominance of the Omicron variant (7.1 per 100,000 population) [<a href="#rid75">75,76</a>]. A smaller peak followed in August 2022, with the predominance of Omicron subvariants [<a href="#rid76">76</a>]. Despite increasing numbers of hospitalizations with Delta and Omicron variants, the proportions of hospitalized children requiring intensive care or invasive mechanical ventilation was similar with Delta and lower with Omicron than with earlier circulating strains [<a href="#rid76">76,77</a>].</p><p></p><p class="bulletIndent1">During the Omicron predominant periods, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fmmwr%2Fvolumes%2F71%2Fwr%2Fmm7145a3.htm%23F1_down&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLDUG08ZbGAJiu0qbyu%2F2zoKuRxEYQHQtUon3Tr6YGpOZwosq%2BGtwz89ld1SWc4zJtgJmO0hcGtEscPCfnN3uMGY%3D&amp;TOPIC_ID=127488" target="_blank">weekly hospitalization rates</a> were particularly high in infants younger than six months, who remain ineligible for vaccination, and in children age six months through four years, who were not eligible for vaccination until June 2022 [<a href="#rid76">76,78</a>]. Among children age 5 to 11 years (who became eligible for vaccination in early November 2021), <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fmmwr%2Fvolumes%2F71%2Fwr%2Fmm7116e1.htm%23F1_down&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLDUG08ZbGAJiu0qbyu%2F2zoLgIgc7m492VTMW1R0bNPZyDCUxqorLXCeshM0g%2B1MC%2BgJmO0hcGtEscPCfnN3uMGY%3D&amp;TOPIC_ID=127488" target="_blank">hospitalization rates</a> were approximately twice as high in unvaccinated than in vaccinated children (19 versus 9 per 100,000) during the period of early Omicron predominance (December 19, 2021 to February 28, 2022) [<a href="#rid77">77</a>]. Higher proportions of unvaccinated than fully vaccinated adolescents had COVID-19 as the primary reason for hospitalization (70 versus 41 percent) and required intensive care (30 versus 16 percent) [<a href="#rid76">76</a>].</p><p></p><p class="bulletIndent1">Underlying conditions are associated with higher rates of hospitalization and intensive care unit (ICU) admission [<a href="#rid79">79</a>]. Whether underlying conditions are associated with increased severity or a lower threshold for admission (eg, because of concern for complications) is unclear [<a href="#rid80">80</a>]. Age &lt;1 year has also been associated with increased rates of hospitalization [<a href="#rid1">1,81</a>], although hospitalization of infants may not reflect severity of illness.</p><p></p><p class="bulletIndent1">With universal testing for SARS-CoV-2 upon admission at most hospitals, the rates of hospitalization for SARS-CoV-2 in children may be overestimated if hospitalizations for SARS-CoV-2-related illness are not differentiated from hospitalizations for other reasons (eg, elective surgery, trauma) with incidental detection of SARS-CoV-2 [<a href="#rid82">82</a>], particularly when highly transmissible variants are circulating.</p><p></p><p class="bulletIndent1">Additional information regarding hospitalization of children in the United States is available through the CDC's COVID-19-Associated Hospitalization Surveillance Network (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcovid-data%2Fcovid-net%2Fpurpose-methods.html&amp;token=2q8A2fyAcIrdSqqCDoBG8iY2dSFWhWC24mG5teKRKzOr1KvVOdJE5Fbu26Z9%2B143spPgPrbjSv2Rktq4eilQvP90Og66i%2B%2Bt19eJIOTI6pE%3D&amp;TOPIC_ID=127488" target="_blank">COVID-NET</a>) [<a href="#rid75">75</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Death </strong>– SARS-CoV-2-related death in children and adolescents is rare [<a href="#rid83">83</a>]. In pooled analysis from seven countries (France, Germany, Italy, Spain, South Korea, the United Kingdom, and the United States), the COVID-19-related death rate among children (age 0 to 19 years) was 0.17 per 100,000 population as of February 2021 [<a href="#rid84">84,85</a>]. In the United States, as of June 1, 2022, there were &gt;13 million cases of COVID-19 and 1533 COVID-19-associated deaths in children &lt;18 years of age reported to the CDC [<a href="#rid69">69</a>]. Between August 1, 2021 and July 31, 2022 (during the emergence of the Delta and Omicron variants), the crude death rate for COVID-19 among children (0 to 19 years) in the United States was 1.0 per 100,000 overall; the crude death rate was greater among those younger than 1 year (4.3 per 100,000) and those age 15 to 19 years (1.8 per 100,000) than in other age groups (ranging from 0.4 to 0.6 per 100,000) [<a href="#rid86">86</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Racial and ethnic disparities</strong> – Children from underrepresented racial and ethnic groups appear to be disproportionately affected by acute COVID-19 and COVID-19-associated hospitalizations and deaths, perhaps related to social determinants of health (ie, conditions in the places where people live, learn, work, play, and worship) [<a href="#rid87">87,88</a>]. As of May 2022, COVID-19 hospitalization rates were 2.2 to 2.5 times greater among non-Hispanic American Indian/Alaska Native children, non-Hispanic Black children, and Hispanic/Latino children than among non-Hispanic White children &lt;18 years of age (158.5 to 179.2 versus 72 per 100,000 population) [<a href="#rid87">87</a>]. SARS-CoV-2-related deaths are disproportionately represented among Hispanic/Latino children, non-Hispanic Black children, non-Hispanic Native Hawaiian/other Pacific Islander children, and non-Hispanic American Indian/Alaska Native children.</p><p></p><p class="headingAnchor" id="H4024949724"><span class="h2">Risk factors for severe disease</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Host factors</strong> – Although children with underlying medical conditions are at greater risk for severe disease (eg, hospitalization, need for intensive care or mechanical ventilation, death) than children without underlying conditions [<a href="#rid68">68,79,89-101</a>], robust evidence associating specific underlying conditions with severe illness in children is limited [<a href="#rid96">96,102</a>].</p><p></p><p class="bulletIndent1">The following conditions may be associated with increased risk of severe disease in children [<a href="#rid81">81,91,96,97,103,104</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Medical complexity</p><p class="bulletIndent2"><span class="glyph">•</span>Genetic conditions</p><p class="bulletIndent2"><span class="glyph">•</span>Neurologic conditions [<a href="#rid101">101,105,106</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Metabolic conditions</p><p class="bulletIndent2"><span class="glyph">•</span>Congenital heart disease/cardiovascular disease [<a href="#rid101">101,106-111</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Obesity (body mass index &gt;95<sup>th</sup> percentile for age and sex (<a class="calc calc_professional" href="/z/d/html/13412.html" rel="external">calculator 1</a> and <a class="calc calc_professional" href="/z/d/html/13415.html" rel="external">calculator 2</a>)) [<a href="#rid89">89,98,101,105,106,112,113</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Diabetes mellitus [<a href="#rid106">106,112</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Chronic pulmonary diseases; the evidence for asthma is inconsistent [<a href="#rid89">89,98,105,106,111,114</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Sickle cell disease [<a href="#rid115">115</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Immunosuppression</p><p class="bulletIndent2"><span class="glyph">•</span>Being unvaccinated or not being up-to-date on COVID-19 vaccination [<a href="#rid116">116</a>]</p><p></p><p class="bulletIndent1">Having multiple underlying conditions is also associated with an increased risk of severe disease [<a href="#rid106">106,117</a>]. In multicenter studies of children admitted to ICUs with SARS-CoV-2-related illness and case series of SARS-CoV-2-related deaths in children, most (but not all) children had one or more underlying conditions [<a href="#rid90">90,91,100,101</a>]. The most common underlying conditions included chronic pulmonary disease, obesity, neurologic and developmental conditions, and cardiovascular conditions.</p><p></p><p class="bulletIndent1">Although immune compromise has been reported as an underlying condition in children with severe COVID-19 disease in some case series, the relationship between immune compromise and severe COVID-19 disease has not been well established. In small surveys of children who developed COVID-19 while receiving immunosuppressive medications for kidney disease, inflammatory bowel disease, and rheumatic disease, COVID-19 was mild [<a href="#rid118">118-121</a>]. In another study that included eight children with rheumatic disease, active disease and use of glucocorticoids were associated with severe disease [<a href="#rid122">122</a>].</p><p></p><p class="bulletIndent1">Childhood cancer appears to be associated with increased severity of COVID-19 disease. In a global registry study of COVID-19 in children with cancer including 1500 patients, 20 percent had severe or critical infection, and mortality (4 percent) was higher than that in the general pediatric population [<a href="#rid123">123</a>]. Among children with cancer, severe disease has been associated with intensive chemotherapy, neutropenia, lymphopenia, comorbidity, and coinfection [<a href="#rid123">123,124</a>]. Children with hematologic malignancy do not appear to be at greater risk of severe COVID-19 than children with nonhematologic malignancy [<a href="#rid125">125</a>].</p><p></p><p class="bulletIndent1">Other conditions that may be associated with severe disease in children, but for which the evidence is inconsistent, include age &lt;1 year [<a href="#rid93">93,100,106,126,127</a>], Down syndrome [<a href="#rid128">128,129</a>], and prematurity (gestational age &lt;37 weeks) [<a href="#rid112">112,130</a>].</p><p></p><p class="bulletIndent1">Whether vitamin D deficiency increases the risk of SARS-CoV-2 infection in children is uncertain [<a href="#rid131">131</a>]. The association may be confounded by other risk factors for both vitamin D deficiency and SARS-CoV-2 infection (eg, obesity) [<a href="#rid132">132,133</a>]. Vitamin D deficiency in children, including indications for screening (which are unchanged by the COVID-19 pandemic), is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14590.html" rel="external">"Vitamin D insufficiency and deficiency in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1">Underlying conditions that increase or may increase the risk of severe disease in adults are discussed separately  (<a class="graphic graphic_table graphicRef127477" href="/z/d/graphic/127477.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">"COVID-19: Clinical features", section on 'Risk factors for severe illness'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Virus factors </strong>– COVID-19 disease severity may be related to the strain of SARS-CoV-2 [<a href="#rid134">134-138</a>]. In observational studies in children and adolescents, the rates of admission to the ICU and mechanical ventilation were lower with the Omicron than the Delta variant [<a href="#rid134">134,135,139</a>].</p><p></p><p class="bulletIndent1">The association between SARS-CoV-2 variants and severity of disease is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/126981.html" rel="external">"COVID-19: Epidemiology, virology, and prevention", section on 'Variants of concern'</a>.)</p><p></p><p class="headingAnchor" id="H827791115"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The clinical features of COVID-19 are discussed in detail separately. This section focuses on the clinical features of acute COVID-19 in children. (See  <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">"COVID-19: Clinical features"</a>.)</p><p class="headingAnchor" id="H186180572"><span class="h2">Spectrum of disease severity</span><span class="headingEndMark"> — </span>The clinical spectrum of SARS-CoV-2 infections in children ranges from asymptomatic to life-threatening. Although severe and fatal cases have been reported, most children appear to have asymptomatic or nonsevere symptomatic infections [<a href="#rid5">5,79,140-142</a>]. (See <a class="local">'Severe disease in children'</a> below and <a class="local">'Hospitalization and death'</a> above.)</p><p>Asymptomatic infection is common in children. In a 2020 systematic review of 18 reviews of symptoms and signs in children &lt;20 years of age with documented SARS-CoV-2 infection, the proportion of asymptomatic infections ranged from 15 to 42 percent [<a href="#rid143">143</a>]. In a subsequent review of electronic health records of 82,798 United States children &lt;18 years of age with laboratory-confirmed SARS-CoV-2 infection between March 2020 and December 2021, 66 percent were asymptomatic, 27 percent were mild (COVID-19-related symptoms), 5 percent were moderate (moderately severe COVID-19-related condition such as pneumonia, gastroenteritis, dehydration), and 2 percent were severe (unstable COVID-19-related condition, requiring intensive care unit [ICU] admission or mechanical ventilation) [<a href="#rid140">140</a>].</p><p>Among children with COVID-19 admitted to the ICU, the severity appears to be similar to that of influenza. In a multicenter study comparing children admitted to the ICU with influenza and children admitted to the ICU with COVID-19, approximately 30 percent in each group required mechanical ventilation, 20 percent required vasopressor support, and 2 to 3 percent required extracorporeal membrane oxygenation [<a href="#rid144">144</a>].</p><p>Why severe COVID-19 appears to be less frequent in children than in adults is unclear. One possibility is that children have a less-intense immune response to the virus than adults; cytokine release syndrome is thought to be important in the pathogenesis of severe COVID-19 infections [<a href="#rid145">145-147</a>]. Other possibilities include: viral interference in the respiratory tract of young children, which may lead to a lower SARS-CoV-2 viral load; different expression of the angiotensin converting enzyme 2 receptor (the receptor for SARS-CoV-2) in the respiratory tracts of children and adults; pre-existing cross-reactive antibody; a vigorous early mucosal immune response; protective off-target effects of live vaccines; relatively healthier blood vessels in children than in adults; developmental differences in adaptive immune responses during the first years of life; and age-related differences in the nasopharyngeal microbiome [<a href="#rid148">148-158</a>].</p><p class="headingAnchor" id="H2167437221"><span class="h2">Clinical findings</span></p><p class="headingAnchor" id="H255026123"><span class="h3">In children of all ages</span><span class="headingEndMark"> — </span>Children of all ages can be infected with SARS-CoV-2. Males and females are equally affected [<a href="#rid79">79</a>].</p><p>The clinical presentation of symptomatic SARS-CoV-2 infection in children is variable and overlaps with other clinical syndromes (eg, pneumonia, bronchiolitis, croup, e-cigarette or vaping product use-associated lung injury [<a href="#rid159">159</a>], gastroenteritis). The clinical presentation is similar in immunocompetent and immunocompromised children [<a href="#rid160">160</a>].</p><p>In case surveillance in the United States, commonly reported symptoms among children and adolescents included [<a href="#rid68">68,79</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Fever</p><p class="bulletIndent1"><span class="glyph">●</span>Cough</p><p class="bulletIndent1"><span class="glyph">●</span>Shortness of breath</p><p class="bulletIndent1"><span class="glyph">●</span>Myalgia</p><p class="bulletIndent1"><span class="glyph">●</span>Rhinorrhea</p><p class="bulletIndent1"><span class="glyph">●</span>Sore throat</p><p class="bulletIndent1"><span class="glyph">●</span>Headache</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea/vomiting</p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal pain</p><p class="bulletIndent1"><span class="glyph">●</span>Diarrhea</p><p class="bulletIndent1"><span class="glyph">●</span>Loss of smell or taste (in nonverbal children, this may manifest as solid food aversion or refusal) [<a href="#rid161">161</a>]</p><p></p><p>The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fmmwr%2Fvolumes%2F69%2Fwr%2Fmm6924e2.htm%23T2_down&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLDUG08ZbGAJiu0qbyu%2F2zoJrBmue3rMcwXdk9benfkERzmsnHTDS1O9Xn4E1Hj0iFgckW77DlerPTqVXmy%2Ffz%2Fw%3D&amp;TOPIC_ID=127488" target="_blank">frequency of specific symptoms varies with age</a> [<a href="#rid79">79</a>]. During the first months of the pandemic, fever, cough, or shortness of breath were reported in ≥60 percent of children and adolescents. Myalgia, sore throat, and headache were more frequently reported in children ≥10 years of age than in younger children (approximately 30 to 40 percent versus 10 to 15 percent). Loss of smell or taste was also more frequently reported among older children (approximately 10 versus 1 percent) [<a href="#rid79">79</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory tract symptoms</strong> – Although symptoms of respiratory tract infection are common, the frequency of specific symptoms may vary with the SARS-CoV-2 variant. Early in the pandemic, fever or chills and cough were the most frequently reported symptoms in children and adolescents [<a href="#rid68">68,79,143</a>]. During the predominance of the Delta and Omicron variants, nasal congestion, headache, sneezing, sore throat, and croup-like symptoms were more common; sore throat and altered sense of smell were more common with Delta than Omicron [<a href="#rid162">162-169</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastrointestinal symptoms</strong> – Gastrointestinal symptoms may occur without respiratory symptoms [<a href="#rid4">4,148,170-172</a>]. Diarrhea, vomiting, and abdominal pain are the most common gastrointestinal symptoms reported in children [<a href="#rid1">1,170,173-175</a>]. Acute cholestasis, pancreatitis, and hepatitis have also been reported [<a href="#rid176">176-182</a>]. (See  <a class="medical medical_review" href="/z/d/html/8339.html" rel="external">"Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection", section on 'Acute hepatitis'</a> and  <a class="medical medical_review" href="/z/d/html/16142.html" rel="external">"Acute liver failure in children: Etiology and evaluation", section on 'Outbreak 2022'</a>.)</p><p></p><p class="bulletIndent1">In a retrospective study, the prevalence of SARS-CoV-2 positivity in children with acute gastroenteritis (&gt;3 episodes of vomiting or diarrhea in 24 hours) was similar to that in children with isolated respiratory symptoms (approximately 7 to 8 percent) [<a href="#rid183">183</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurologic manifestations</strong> – Neurologic manifestations have been described in children hospitalized with acute COVID-19 and may be life threatening [<a href="#rid184">184-186</a>]. In a cross-sectional multicenter study of 15,137 children hospitalized with COVID-19 or a COVID-19-associated complication, 7 percent had one or more neurologic complications, including febrile seizures in 3.8 percent, nonfebrile seizures in 2.3 percent, and encephalopathy in 2.2 percent; less common neurologic complications included brain abscess, bacterial meningitis, and cerebral infarction [<a href="#rid184">184</a>]. Neurologic manifestations reported in other studies include stroke, central nervous system infection/demyelination, Guillain-Barré syndrome/variants, acute fulminant cerebral edema, headache, weakness, anosmia, ageusia, and delirium [<a href="#rid185">185-188</a>]. Seizures in febrile children with COVID-19 appear to be more common with the Omicron variant than with earlier variants [<a href="#rid189">189</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cutaneous findings</strong> – Cutaneous findings have been reported infrequently and are not well characterized; they include maculopapular, urticarial, and vesicular eruptions; transient livedo reticularis; and acral peeling [<a href="#rid190">190-194</a>]. Reddish-purple nodules on the distal digits  (<a class="graphic graphic_picture graphicRef128273 graphicRef129621" href="/z/d/graphic/128273.html" rel="external">picture 1A-B</a>) (sometimes called "COVID toes") are described predominantly in children and young adults, although an association with COVID-19 has not been clearly established. (See  <a class="medical medical_review" href="/z/d/html/127978.html" rel="external">"COVID-19: Cutaneous manifestations and issues related to dermatologic care", section on 'Cutaneous manifestations of COVID-19'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiovascular abnormalities</strong> – Cardiovascular abnormalities (eg, heart failure, arrhythmias, myocarditis, pericarditis, cardiogenic shock, pulmonary embolism, ST elevation myocardial infarction) have been reported in small case series [<a href="#rid5">5,195-202</a>]. COVID-19 is associated with an increased risk of myocarditis, but the absolute risk is low (&lt;0.15 percent) [<a href="#rid203">203</a>].</p><p></p><p class="bulletIndent1">The risk of COVID-19 vaccine-associated myocarditis is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/129849.html" rel="external">"COVID-19: Vaccines", section on 'Myocarditis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Kidney dysfunction</strong> – Kidney dysfunction may occur in severely ill children and those with multisystem inflammatory syndrome in children (MIS-C) [<a href="#rid204">204,205</a>]. The incidence of acute kidney injury (AKI) in children with COVID-19 ranges from &lt;1 to 70 percent, varying with the study population, AKI definition, and geographic location [<a href="#rid204">204</a>]. In a retrospective analysis of 2546 children (&lt;21 years) admitted to ICUs in the United States with documented SARS-CoV-2 infection, 10.8 percent had AKI (determined by Kidney Disease Improving Global Outcomes staging  (<a class="graphic graphic_table graphicRef93722" href="/z/d/graphic/93722.html" rel="external">table 2</a>)): 62.8 percent had stage 1, 14.6 percent had stage 2, and 22.6 percent had stage 3 [<a href="#rid204">204</a>].</p><p></p><p class="headingAnchor" id="H4111682027"><span class="h3">In infants &lt;12 months of age</span><span class="headingEndMark"> — </span>Additional presentations associated with SARS-CoV-2 infection in infants &lt;12 months of age include:</p><p class="bulletIndent1"><span class="glyph">●</span>Feeding difficulty [<a href="#rid68">68,206-209</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Fever without an obvious source [<a href="#rid210">210-212</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Intussusception [<a href="#rid213">213</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Bronchiolitis [<a href="#rid214">214,215</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Apnea [<a href="#rid216">216</a>]</p><p></p><p>Respiratory symptoms may be minimal in infants; when present, they are similar to those caused by other coronaviruses and influenza, although cough may be less prominent [<a href="#rid217">217</a>].</p><p>In a multicenter registry study of 232 infants &lt;12 months of age hospitalized with documented acute COVID-19 infection during 2020, approximately 55 percent had severe disease (as defined by severe involvement of one or more organ systems) [<a href="#rid127">127,218</a>]. Among infants with severe disease, two-thirds were previously healthy; most had respiratory complications and 13 percent required mechanical ventilation.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Special infant populations</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neonates</strong> – In a registry study of 176 neonates (&lt;28 days of age) who acquired SARS-CoV-2 infection after discharge from the birth hospital, symptoms included [<a href="#rid207">207</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Fever – 64 percent</p><p class="bulletIndent3"><span class="glyph">-</span>Feeding intolerance – 26 percent</p><p class="bulletIndent3"><span class="glyph">-</span>Cough – 22 percent</p><p class="bulletIndent3"><span class="glyph">-</span>Tachypnea – 19 percent</p><p class="bulletIndent3"><span class="glyph">-</span>Diarrhea – 8 percent</p><p class="bulletIndent3"><span class="glyph">-</span>Rhinorrhea – 8 percent</p><p class="bulletIndent3"><span class="glyph">-</span>Somnolence/irritability – 7 percent</p><p class="bulletIndent3"><span class="glyph">-</span>Rash – 2 percent</p><p></p><p class="bulletIndent2">In a separate retrospective cross-sectional study using electronic health record data, COVID-19 was diagnosed in 918 neonates (91 per 100,000 neonatal encounters) [<a href="#rid219">219</a>]. The median age at diagnosis was 14.5 days. Most neonates (64 percent) were asymptomatic at initial presentation. Among symptomatic infants, tachypnea and fever were the most common presenting signs and 28 percent had pneumonia. Approximately 8 percent of neonates had severe infection.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Preterm infants</strong> – Hyperglycemia and bone marrow dysfunction (leukopenia or leukocytosis) have been reported in preterm infants with SARS-CoV-2 infection [<a href="#rid220">220</a>].</p><p></p><p class="headingAnchor" id="H1359939953"><span class="h2">Severe disease in children</span><span class="headingEndMark"> — </span>A consensus definition for severe disease in children is lacking and different definitions have been used in studies categorizing severity. Using a definition of severe disease that encompasses care in an ICU/step-down unit, requiring invasive mechanical ventilation, or in-hospital death, approximately one-third of children in the United States with COVID-19-related hospitalization have severe disease [<a href="#rid89">89,117,221</a>]. This proportion remained relatively stable or declined with the predominance of the Delta and Omicron variants [<a href="#rid76">76</a>].</p><p>An observational study that compared characteristics of severe acute COVID-19 with MIS-C defined severe acute COVID-19 by [<a href="#rid218">218</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A positive polymerase chain reaction test for SARS-CoV-2, and</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe organ system involvement in at least one of the following systems:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Respiratory (eg, receipt of supplemental oxygen or increased respiratory support [for those receiving respiratory support at baseline], severe bronchospasm, lower respiratory infection, pleural effusion)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiovascular (eg, dysrhythmia/ arrhythmia, pulmonary edema due to left heart failure, coronary artery aneurysm, receipt of vasopressor/vasoactive support)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Kidney (eg, AKI or receipt of dialysis)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neurologic (eg, stroke, acute intracranial hemorrhage, seizures, encephalitis)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Gastrointestinal (eg, appendicitis, pancreatitis, hepatitis)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hematologic (eg, lymphopenia, neutropenia, severe anemia, deep vein thrombosis, pulmonary embolism)</p><p></p><p>Although the clinical features of severe acute COVID-19 and MIS-C overlap, they have differing patterns of clinical presentation and organ involvement, which may help in their differentiation (eg, severe pulmonary involvement is more prominent in severe acute COVID-19,whereas severe cardiac involvement is more prominent in MIS-C). (See  <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis", section on 'Differentiating MIS-C and acute COVID-19'</a>.)</p><p>Clinical and laboratory findings that are associated with severe disease include [<a href="#rid4">4,94,218,222-225</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Dyspnea, tachypnea, tachycardia, hypotension, and/or hypoxia at admission</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gastrointestinal symptoms at admission</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Elevated inflammatory markers (eg, C-reactive protein, procalcitonin, interleukin 6, ferritin, D-dimer) at admission or during hospitalization</p><p></p><p class="headingAnchor" id="H4240874865"><span class="h2">Clinical course</span><span class="headingEndMark"> — </span>Although most children with nonsevere symptomatic acute SARS-CoV-2 infection recover within one to two weeks of disease onset [<a href="#rid5">5,79,140,226</a>], clinical deterioration may occur suddenly after approximately one week of symptoms and should prompt urgent re-evaluation, ideally at a medical center with expertise in caring for children with COVID-19 [<a href="#rid227">227</a>].</p><p>In a prospective cohort study with voluntary mobile application-based reporting of symptoms by an adult proxy, the median duration of illness was six days (interquartile range [IQR] 3 to 11 days) in 1734 children who tested positive for SARS-CoV-2 compared with three days (IQR 2 to 7 days) in a matched cohort of children who tested negative [<a href="#rid226">226</a>]; approximately 2 percent of each group presented to an emergency department or were hospitalized. Median duration of SARS-CoV-2 illness was shorter in children age 5 to 11 than 12 to 17 years (5 versus 7 days).</p><p class="headingAnchor" id="H3856904233"><span class="h2">Complications</span></p><p class="headingAnchor" id="H2722465728"><span class="h3">MIS-C</span><span class="headingEndMark"> — </span>Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious condition associated with COVID-19. The clinical features of MIS-C may be similar to those of Kawasaki disease, Kawasaki disease shock syndrome, and toxic shock syndrome. They include persistent fever, hypotension, gastrointestinal symptoms, rash, myocarditis, and laboratory findings associated with increased inflammation; respiratory symptoms may be lacking  (<a class="graphic graphic_table graphicRef128294 graphicRef128201" href="/z/d/graphic/128294.html" rel="external">table 3A-B</a>).</p><p>MIS-C is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis"</a>.)</p><p class="headingAnchor" id="H128917291"><span class="h3">Post-COVID-19 condition ("long COVID")</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – The <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Fclinical-care%2Fpost-covid-conditions.html%23management&amp;token=4qSTj5qcNWjauARBcNTVWZPUEwKbEBH69pfQpEMLoddqSIxYWv%2FQgQ3UGB5CV0FkhjtJcq5LxWQxNCzvrX486Cn%2BRhubQPoknM4P9lF%2BIyYix8m5I4UzTPJ%2Bm449%2BIb6&amp;TOPIC_ID=127488" target="_blank">Centers for Disease Control and Prevention</a> (CDC), <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.aap.org%2Fen%2Fpages%2F2019-novel-coronavirus-covid-19-infections%2Fclinical-guidance%2Fpost-covid-19-conditions-in-children-and-adolescents%2F&amp;token=FMG%2Btf9XjE%2FxJgCOaMiwXlaYeov%2FLleIRSKNqGrNm1CVdNADSMakGrPgEat8MaF8iwb4o%2FjVWfe%2B2ixHpyaioI2kZeUFgsHmFfGwxQAIwDOpm89w1hSsRWXLE1lp34%2FSbrQKM8UNuU6zCbtI1Pqwng%3D%3D&amp;TOPIC_ID=127488" target="_blank">American Academy of Pediatrics</a>, and World Health Organization (WHO) use the umbrella term "post-COVID-19 condition" for the broad range of persistent, recurrent, or novel physical and mental health symptoms and conditions that are present ≥4 weeks after SARS-CoV-2 infection (of any severity); this condition is also called "long COVID" or "post-acute sequelae of SARS-CoV-2 infection" (PASC) [<a href="#rid228">228-230</a>].</p><p></p><p class="bulletIndent1">The WHO provides a consensus <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fpublications%2Fi%2Fitem%2FWHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1&amp;token=jfJI%2F4ECc%2FWmj1d6Am8kb9KgD7iZsetFV56BUm565T31XanvdpIkxJWy0zsDs1FlYU58FKJvm6fF2FpCI%2B5n3bPLsJ0HtTVqqYbJhbVS4Gb3mq8wcEjJyKTiR0e6HIWpx7c%2FX%2FARAtoYBPEk3Z%2B3nw%3D%3D&amp;TOPIC_ID=127488" target="_blank">clinical case definition</a> that can be applied to children of all ages and includes [<a href="#rid230">230</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Confirmed or probable SARS-CoV-2 infection</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Symptoms lasting ≥2 months and that initially occurred within three months of acute COVID-19</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In a systematic review, fatigue, altered smell/anosmia, and anxiety were more frequent among children with post-COVID-19 condition than controls (without post-COVID-19 condition); a wide range of other potential symptoms may occur (eg, cough, cognitive difficulty, diarrhea)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Symptoms may be persistent or of new onset and may fluctuate or recur over time</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Symptoms affect everyday function (eg, eating habits, physical activity, interaction with friends and family, school performance)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Co-occurrence of other diagnoses does not exclude the diagnosis of post-COVID-19</p><p></p><p class="bulletIndent1">The WHO definition may change over time as more information becomes available [<a href="#rid230">230</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Prevalence</strong> – The prevalence of post-COVID-19 symptoms and conditions is unclear [<a href="#rid231">231,232</a>]. Ongoing follow-up of children with COVID-19 is necessary to better define the long-term outcome. Examples of relevant studies include the following:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Children hospitalized with COVID-19</strong> –<strong> </strong>In prospective observational studies of children hospitalized with acute COVID-19, approximately 10 to 27 percent report persistent symptoms or activity impairment two to five months after discharge [<a href="#rid233">233-235</a>]. In a review of administrative claims of 372 commercially insured children who were hospitalized with acute COVID-19, 20 percent had at least one SARS-CoV-2 sequelae-related readmission and 91 percent had at least one sequelae-related health care visit (median of six visits) in the five months after discharge; at least 25 percent had a sequelae-related visit in the fifth month [<a href="#rid236">236</a>]. Sequelae-related visits included cardiovascular (eg, dysrhythmia, pericarditis myocarditis), respiratory (eg, lower respiratory tract disease), gastrointestinal (eg, abdominal pain), and mental health (eg, anxiety, mood disorder) diagnoses.</p><p></p><p class="bulletIndent3">A retrospective cohort study was conducted in a European country where the health registries achieve almost complete data acquisition of all citizens [<a href="#rid237">237</a>]. Of the more than 160,000 children aged 6 to 17 years diagnosed with COVID-19 between January 31, 2020 and February 9, 2022, 0.2 percent were subsequently diagnosed with post-COVID-19. The incidence per 100 person-years was higher among children hospitalized for COVID-19 treatment (1.25 percent, 95% CI 0.62-2.23) than those who were not (0.15 percent, 95% CI 0.13-0.17).</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Children treated as outpatients for COVID-19</strong> –<strong> </strong>In a retrospective cohort study of electronic health records of 659,286 children &lt;21 years of age (59,893 with a positive COVID-19 test), the incidence of ≥1 clinical feature of a post-COVID-19 condition (eg, symptom, syndrome/condition, or use of medication) was slightly greater in children with than without COVID-19 (41.9 versus 38.2 percent; proportion difference 3.7 percent, 95% CI 3.2-4.2) [<a href="#rid238">238</a>]. These findings support those of an earlier systematic review in which the proportion difference was 3 percent, underscoring the challenge of distinguishing symptoms related to SARS-CoV-2 infection from those related to the pandemic [<a href="#rid239">239,240</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Risk factors </strong>– Among children with acute COVID-19, post-COVID-conditions appear to be associated with severe symptoms during initial infection, hospitalization, the number of organ systems involved, the number of symptoms at presentation, lack of vaccination against COVID-19, and body mass index ≥85<sup>th</sup> percentile for age and sex [<a href="#rid233">233,235,237,238,241</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features </strong>– Commonly reported symptoms include fatigue, weakness, headache, sleep disturbance, muscle and joint pain, respiratory problems, palpitations, and altered sense of smell or taste [<a href="#rid226">226,233-235,242-250</a>]. Other symptoms include dizziness and dysautonomia [<a href="#rid250">250,251</a>].</p><p></p><p class="bulletIndent1">Whether post-COVID-19 symptoms and conditions (eg, fatigue, sleep disturbance) are caused by SARS-CoV-2 infection or related to the pandemic is unclear [<a href="#rid231">231,252,253</a>]. The CDC analyzed medical claims of &gt;781,400 children &lt;18 years of age with documented COVID-19 and &gt;2.3 million children without COVID-19 (or with unrecognized COVID-19) who were followed between 60 and 365 days to identify which symptoms and conditions were more likely among children with COVID-19 [<a href="#rid246">246</a>]. In general, symptoms/conditions that were more likely in children with COVID-19 were serious and rare or uncommon (incidence ranging from 13 to 817 per 100,000), and symptoms/conditions that were only slightly more likely or less likely in children with COVID-19 were less serious and more common (incidence &gt;4600 per 100,000) [<a href="#rid246">246</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Symptoms/conditions that were more likely among children with than without COVID-19 included [<a href="#rid246">246</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Pulmonary embolism (adjusted hazard ratio [aHR] 2.01)</p><p class="bulletIndent3"><span class="glyph">-</span>Myocarditis and cardiomyopathy (aHR 1.99)</p><p class="bulletIndent3"><span class="glyph">-</span>Venous thromboembolic events (aHR 1.87)</p><p class="bulletIndent3"><span class="glyph">-</span>Acute and unspecified renal failure (aHR 1.32)</p><p class="bulletIndent3"><span class="glyph">-</span>Type 1 diabetes mellitus (aHR 1.23)</p><p class="bulletIndent3"><span class="glyph">-</span>Coagulation and hemorrhagic disorders (aHR 1.18)</p><p class="bulletIndent3"><span class="glyph">-</span>Smell and taste disturbances (aHR 1.17)</p><p class="bulletIndent3"><span class="glyph">-</span>Type 2 diabetes (aHR 1.17)</p><p class="bulletIndent3"><span class="glyph">-</span>Cardiac dysrhythmias (1.16)</p><p></p><p class="bulletIndent2">These findings are supported by a similar multicenter cohort study in which myocarditis and loss of smell or taste were more likely in children with COVID-19 [<a href="#rid238">238</a>] and a retrospective cohort study in which COVID-19 infection in children &lt;18 years of age was associated with increased health care utilization for pulmonary embolism or deep vein thrombosis, arrhythmias, dyspnea, and ear nose and throat disorders [<a href="#rid254">254</a>].</p><p></p><p class="bulletIndent2">In a separate multicenter cohort study that evaluated neurologic and psychiatric trajectories following COVID-19 infection in 185,748 children with COVID-19, children with COVID-19 had an increased risk of cognitive deficit; insomnia; intracranial hemorrhage; ischemic stroke; nerve, nerve root, and plexus disorders; psychotic disorders; and seizures in the six months after infection compared with matched controls with any other respiratory infection [<a href="#rid247">247</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the CDC study, symptoms/conditions that were only slightly more likely in children with COVID-19 included [<a href="#rid246">246</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Circulatory signs and symptoms (aHR 1.07)</p><p class="bulletIndent3"><span class="glyph">-</span>Malaise and fatigue (aHR 1.05)</p><p class="bulletIndent3"><span class="glyph">-</span>Musculoskeletal pain (aHR 1.02)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the CDC study, symptoms/conditions that were less or equally likely in children with COVID-19 included [<a href="#rid246">246</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Respiratory symptoms</p><p class="bulletIndent3"><span class="glyph">-</span>Anxiety and fear-related disorders</p><p class="bulletIndent3"><span class="glyph">-</span>Gastroesophageal and esophageal disorders</p><p class="bulletIndent3"><span class="glyph">-</span>Asthma</p><p></p><p>Follow-up of children with SARS-CoV-2 infection and persistent symptoms, and persistent symptoms in adults with COVID-19, are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/128389.html" rel="external">"COVID-19: Management in children", section on 'Follow-up'</a> and  <a class="medical medical_review" href="/z/d/html/129312.html" rel="external">"COVID-19: Evaluation and management of adults with persistent symptoms following acute illness ("Long COVID")", section on 'Persistent symptoms'</a>.)</p><p class="headingAnchor" id="H45502851"><span class="h2">Reinfection</span><span class="headingEndMark"> — </span>The risk of reinfection increased with the emergence of the Omicron variant and Omicron sublineages  (<a class="graphic graphic_table graphicRef131216" href="/z/d/graphic/131216.html" rel="external">table 4</a>). Reinfection is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/126981.html" rel="external">"COVID-19: Epidemiology, virology, and prevention", section on 'Risk of reinfection'</a>.)</p><p class="headingAnchor" id="H2478258330"><span class="h1">LABORATORY FINDINGS</span><span class="headingEndMark"> — </span>Laboratory findings in children with symptomatic SARS-CoV-2 infection are variable. In a meta-analysis of 66 studies in children that included 9335 children (0 to 19 years) with documented SARS-CoV-2 (including 1208 with multisystem inflammatory syndrome in children [MIS-C]), mean proportions of children with the following laboratory abnormalities were as follows [<a href="#rid68">68</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated C-reactive protein – 54 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated serum ferritin – 47 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated lactate dehydrogenase – 37 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated D-dimers – 35 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated procalcitonin – 21 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated erythrocyte sedimentation rate – 19 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated leukocytes – 20 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphocytopenia – 19 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphocytosis – 8 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated serum aminotransferases – 30 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated creatine kinase myocardial band – 25 percent</p><p></p><p>Elevated inflammatory markers and lymphocytopenia may indicate MIS-C  (<a class="graphic graphic_table graphicRef128201" href="/z/d/graphic/128201.html" rel="external">table 3B</a>). (See  <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis"</a>.)</p><p class="headingAnchor" id="H3710209062"><span class="h1">IMAGING FINDINGS</span><span class="headingEndMark"> — </span>Imaging findings are variable and may be present before symptoms [<a href="#rid255">255-257</a>]. In a systematic review that included imaging for 3670 children with laboratory-confirmed COVID-19, 44 percent had abnormalities on chest radiograph or computed tomography (CT) [<a href="#rid68">68</a>]. In a separate meta-analysis of 1026 children with laboratory-confirmed COVID-19 who underwent CT imaging of the chest, 36 percent had normal findings and 28 percent had bilateral lesions [<a href="#rid258">258</a>]. Ground glass opacities (37 percent) and consolidation or pneumonic infiltrates (22 percent) were most common. Findings typical of other viral respiratory infections (eg, hyperinflation, peribronchial markings) were not reported. In a small retrospective study from a single institution, 9 of 11 children with multisystem inflammatory syndrome in children (MIS-C) had pleural effusions compared with none of 16 children with COVID-19 without MIS-C [<a href="#rid259">259</a>].</p><p>In a study of eight Italian children hospitalized with documented COVID-19, findings on lung ultrasonography included subpleural consolidations and individual or confluent B lines [<a href="#rid260">260</a>]. These findings were concordant with radiographic findings in seven of the eight patients. They are similar to findings in adult patients with COVID-19. (See  <a class="medical medical_review" href="/z/d/html/14888.html" rel="external">"Bedside pleural ultrasonography: Equipment, technique, and the identification of pleural effusion and pneumothorax", section on 'B lines and lung consolidation'</a> and  <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">"COVID-19: Clinical features", section on 'Lung ultrasound'</a>.)</p><p class="headingAnchor" id="H2219237693"><span class="h1">APPROACH TO DIAGNOSIS</span></p><p class="headingAnchor" id="H2620632429"><span class="h2">Criteria for COVID-19 testing</span><span class="headingEndMark"> — </span>Laboratory testing is necessary to confirm the diagnosis of COVID-19 because no single symptom or combination of symptoms reliably differentiates SARS-CoV-2 from other community-acquired viruses and because coinfection is common [<a href="#rid81">81,261-267</a>].</p><p>Considerations for testing for COVID-19 and information regarding testing may be updated periodically. In the United States, guidance regarding testing is provided by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Ftesting-overview.html&amp;token=PzRDd5i9tUUDIxka8Hm9IlGVtc3EQho6ybkN2aVPtwwq9A%2B7nD9cBV7F%2B64EwOYg383RwDoCh1bn5Ja%2ByNvPObJpMMPl6HE%2BCp2EAcNrKTA%3D&amp;TOPIC_ID=127488" target="_blank">the Centers for Disease Control and Prevention</a> [<a href="#rid268">268</a>], <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.idsociety.org%2Fpractice-guideline%2Fcovid-19-guideline-diagnostics%2F&amp;token=AmHFpeK8AYLtIzjzJcHQsUTZ2ZFEb0AKCpy6VhmjTzNQyH8bUCFj3o%2BUn0pKe1bA84kbEVvEvbi4yk3hRjr%2Bxx6g37ph7JkVjXcN5feSWLM%3D&amp;TOPIC_ID=127488" target="_blank">Infectious Diseases Society of America</a> [<a href="#rid269">269</a>], and the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.aap.org%2Fen%2Fpages%2F2019-novel-coronavirus-covid-19-infections%2Fclinical-guidance%2Fcovid-19-testing-guidance%2F&amp;token=lZC0YophyYL2vMudqNkrDBNxW%2FLLwlIIIx6nyWP%2FKkddwW7ZqsdJceOPuGSDqpROCSxz6rIvjawQLbLl4Ex3eKrLRN9DBmrCKkWOKTZl4c885xEV5Mflekivafrfuqjt&amp;TOPIC_ID=127488" target="_blank">American Academy of Pediatrics</a> [<a href="#rid270">270</a>].</p><p>Testing criteria suggested by the World Health Organization can be found in its <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fpublications%2Fi%2Fitem%2Fdiagnostic-testing-for-sars-cov-2&amp;token=NxpUIkg3K2AGFw8qtm0r%2FljxsSgsegb9%2BTokA6OnbMjX%2BJcnNXx3MAd3BMRZOpwNe2K75a%2BGioitKM789m719lY9H6M3QU7u%2BGFAv3XbkXk%3D&amp;TOPIC_ID=127488" target="_blank">interim guidance on diagnostic testing for SARS-CoV-2</a> online. These are the same criteria used by the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ecdc.europa.eu%2Fen%2Finfectious-disease-topics%2Fz-disease-list%2Fcovid-19%2Ffacts%2Fcase-definition-covid-19&amp;token=7GGiU3hg%2FQ1h8GYpYwvNF9GrUC30jh692zEsy3HVJFOXaiSkZdlidjPBwi8B588MgLJH3if7jNmvU16LBbrXRDUE%2BlFg1ZdQyYSRjYEDleNPeF6wHM7Xdrq2AWTkZ4hc&amp;TOPIC_ID=127488" target="_blank">European Centre for Disease Prevention and Control</a>. Guidance for testing in other countries is discussed separately. (See <a class="local">'Society guideline links'</a> below.)</p><p class="headingAnchor" id="H1257558425"><span class="h3">Outpatient testing criteria</span><span class="headingEndMark"> — </span>In the emergency department, urgent care, or outpatient setting, we perform COVID-19 testing (independent of vaccination status) in children who [<a href="#rid268">268,270</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Have symptoms consistent with COVID-19 (eg, fever, cough, rhinorrhea, shortness of breath, vomiting, diarrhea, sore throat, body aches, fatigue, altered sense of smell or taste), independent of vaccination status, severity of symptoms, and risk for severe disease. (See <a class="local">'Clinical findings'</a> above and <a class="local">'Risk factors for severe disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Have clinical manifestations of multisystem inflammatory syndrome in children  (<a class="graphic graphic_table graphicRef128201" href="/z/d/graphic/128201.html" rel="external">table 3B</a>). (See  <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Have known in-person exposure to a <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fndc.services.cdc.gov%2Fcase-definitions%2Fcoronavirus-disease-2019-2021%2F&amp;token=d8oA%2F7NZfraiyYDWg3l0X2mjpXfnXiSaHPIr06VxIzF1KFHxfMik1%2Fl3kKXRr6s17AzHnnvCqkt00u9Y4AM3Dw53JdLUrYbZhkqCbXBWq%2FY%3D&amp;TOPIC_ID=127488" target="_blank">close contact</a> with laboratory-confirmed case of COVID-19 within the previous 14 days.</p><p></p><p class="bulletIndent1">Symptomatic contacts are tested at the time of presentation; asymptomatic contacts ideally are tested at least five days after the most recent exposure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Develop recurrent symptoms two to eight days after completing treatment with <a class="drug drug_pediatric" data-topicid="134696" href="/z/d/drug information/134696.html" rel="external">nirmatrelvir-ritonavir</a>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Require clearance to return to in-person school attendance after recovery from a symptomatic illness or asymptomatic, nonhousehold COVID-19 exposure.</p><p></p><p class="headingAnchor" id="H2267954405"><span class="h3">Inpatient testing criteria</span><span class="headingEndMark"> — </span>Testing children at the time of admission to the hospital may be beneficial when community transmission is high or in settings where other control measures are limited (eg, shared patient rooms, congregate care, behavioral health issues) [<a href="#rid271">271</a>]. Decisions regarding testing of asymptomatic children at the time of admission usually are made at the institutional level. Several of our institutions test only children who have symptoms of COVID-19 at the time of admission or who develop symptoms during admission. Vaccination status is not considered in the decision. For patients with suspected hospital-acquired acquisition of a respiratory virus, we test for common respiratory pathogens (eg, influenza, respiratory syncytial virus [RSV]) as well as COVID-19 via multiplex reverse transcriptase polymerase chain reaction (PCR).</p><p class="headingAnchor" id="H3143837766"><span class="h3">Asymptomatic individuals</span><span class="headingEndMark"> — </span>In certain circumstances, testing asymptomatic individuals is important for public health or infection control purposes (eg, high-risk congregate settings, hospital admission in communities with high prevalence, preoperative screening). Potential indications for testing asymptomatic individuals are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">"COVID-19: Diagnosis", section on 'Selected asymptomatic individuals'</a>.)</p><p class="headingAnchor" id="H1128362617"><span class="h3">Children with a history of SARS-CoV-2 infection</span><span class="headingEndMark"> — </span>In the United States, the Centers for Disease Control and Prevention (CDC) recommendations for testing (whether to test and preferred type of test) for SARS-CoV-2 in people with a history of SARS-CoV-2 infection vary with the timing of the previous infection. These recommendations are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">"COVID-19: Diagnosis", section on 'Selected asymptomatic individuals'</a> and  <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">"COVID-19: Diagnosis", section on 'Choosing an initial diagnostic test'</a>.)</p><p class="headingAnchor" id="H260195362"><span class="h2">Laboratory tests for SARS-CoV-2</span><span class="headingEndMark"> — </span>The preferred laboratory test for SARS-CoV-2 in children depends upon the clinical scenario (eg, symptoms compatible with COVID-19, duration of symptoms, timing of exposure, surveillance, clearance for a specific setting or event), local guidance, and availability of testing  (<a class="graphic graphic_table graphicRef128419" href="/z/d/graphic/128419.html" rel="external">table 5</a>) [<a href="#rid270">270</a>].</p><p>An approved or authorized PCR test is considered the reference standard for diagnosis of acute SARS-CoV-2 infection in symptomatic children or asymptomatic children with SARS-CoV-2 exposure [<a href="#rid270">270</a>].</p><p>Antigen tests are less sensitive and may require follow-up testing, particularly negative antigen test results in children with symptoms compatible with COVID-19 or high-risk exposures  (<a class="graphic graphic_algorithm graphicRef134206" href="/z/d/graphic/134206.html" rel="external">algorithm 1</a>). In a meta-analysis of cross-sectional or cohort studies of eight point-of-care rapid antigen tests in children, the sensitivity was 64 percent overall (95% CI 57-71 percent; 17 studies, 6287 participants), 72 percent in symptomatic children (95% CI 64-79 percent; 13 studies, 3407 participants), and 56 percent in asymptomatic children (95% CI 48-64 percent; 10 studies, 2431 participants) [<a href="#rid272">272</a>]. The specificity was 99 percent in all groups. In all but one of the included studies, trained staff conducted the tests; results may not be generalizable to other testing conditions.</p><p>Laboratory tests for COVID-19  (<a class="graphic graphic_table graphicRef128419" href="/z/d/graphic/128419.html" rel="external">table 5</a>) and interpretation of laboratory tests for COVID-19 are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">"COVID-19: Diagnosis", section on 'Antigen testing'</a> and  <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">"COVID-19: Diagnosis", section on 'NAAT (including RT-PCR)'</a>.)</p><p class="headingAnchor" id="H3716137487"><span class="h2">Laboratory testing for other viruses</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Influenza and RSV</strong> - During influenza and RSV season, children who are tested for SARS-CoV-2 generally should also be tested for influenza [<a href="#rid104">104,270</a>], and children younger than two years generally should be tested for RSV. Multiplex PCR assays for the three viruses are available, including one that has US Food and Drug Administration emergency use authorization for use without a prescription (the sample is collected at home and sent to a laboratory for testing) [<a href="#rid273">273-277</a>]. The clinical features of SARS-CoV-2 and these viruses overlap [<a href="#rid278">278</a>], and coinfection may occur [<a href="#rid279">279</a>]. The clinical features and diagnosis of influenza and RSV in children are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5973.html" rel="external">"Seasonal influenza in children: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5994.html" rel="external">"Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children", section on 'Infants and young children'</a>.)</p><p></p><p class="bulletIndent1">Confirmation of infection with SARS-CoV-2, influenza, RSV, or coinfection is necessary because the management of these infections differ. (See  <a class="medical medical_review" href="/z/d/html/128389.html" rel="external">"COVID-19: Management in children"</a> and  <a class="medical medical_review" href="/z/d/html/5985.html" rel="external">"Seasonal influenza in children: Management", section on 'Antiviral therapy'</a> and  <a class="medical medical_review" href="/z/d/html/6020.html" rel="external">"Bronchiolitis in infants and children: Treatment, outcome, and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rhinoviruses and enteroviruses </strong>– During late summer and early fall, testing for enterovirus (EV)-D68 may be warranted for children with severe respiratory illness requiring hospitalization and for children with weakness or acute flaccid myelitis. In August 2022, the CDC received reports of increased numbers of children hospitalized with severe respiratory illness who tested positive for rhinoviruses or enteroviruses and noted more detections of EV-D68 than in the three previous years [<a href="#rid280">280</a>]. Additional information is available from the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Femergency.cdc.gov%2Fhan%2F2022%2Fhan00474.asp&amp;token=%2FXpciKoGXD%2FNBcI56myByC8j%2FgwUrJ%2BP4RmkkZzri9PTecXEUOQ30aQZvXnaPvmE8i2rgWZPquNmGz5Js9dHfA%3D%3D&amp;TOPIC_ID=127488" target="_blank">CDC</a>.</p><p></p><p class="bulletIndent1">Enteroviruses, including EV-D68, and acute flaccid myelitis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2693.html" rel="external">"Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention", section on 'Laboratory diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H4090715839"><span class="h2">Detection of other respiratory pathogens</span><span class="headingEndMark"> — </span>Detection of other respiratory pathogens (eg, influenza, RSV, <em>Mycoplasma pneumoniae</em>) in nasopharyngeal specimens does <strong>not</strong> exclude COVID-19 [<a href="#rid3">3,81,100,146,281-286</a>]. In a systematic review of COVID-19 in 1183 children from 26 countries, coinfection was detected in 5.6 percent. <em>M. pneumoniae</em> was most common (58 percent of coinfections), followed by influenza (11 percent) and RSV (9.7 percent) [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H377740281"><span class="h2">Imaging studies</span><span class="headingEndMark"> — </span>Chest imaging is not routinely necessary for the diagnosis of COVID-19 in children [<a href="#rid287">287,288</a>]. It should be obtained as indicated to evaluate clinical findings suggestive of lower respiratory involvement, risk factors for disease progression, potential complications, or worsening respiratory status. Decisions about nonthoracic imaging should be individualized according to clinical findings.</p><p class="headingAnchor" id="H4068508388"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/126613.html" rel="external">"Society guideline links: COVID-19 – Index of guideline topics"</a>.)</p><p class="headingAnchor" id="H3733480921"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/127544.html" rel="external">"Patient education: COVID-19 and children (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/126678.html" rel="external">"Patient education: COVID-19 overview (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/130329.html" rel="external">"Patient education: COVID-19 vaccines (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H1891917909"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology and transmission</strong> – COVID-19 is a pandemic infectious disease caused by SARS-CoV-2. Most cases in children result from household exposure. Children of all ages can transmit SARS-CoV-2 to others in household, child care, educational, and community settings. The relative transmissibility of SARS-CoV-2 by children in various age groups is uncertain. (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Although children with underlying medical conditions have an increased risk for severe disease (eg, hospitalization, need for intensive care, death), robust evidence associating specific underlying conditions with severe illness is limited. Conditions that may be associated with severe disease in children include (see <a class="local">'Risk factors for severe disease'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Medical complexity</p><p class="bulletIndent2"><span class="glyph">•</span>Genetic, neurologic, and metabolic conditions</p><p class="bulletIndent2"><span class="glyph">•</span>Congenital heart disease/cardiovascular disease</p><p class="bulletIndent2"><span class="glyph">•</span>Obesity (body mass index &gt;95th percentile for age and sex (<a class="calc calc_professional" href="/z/d/html/13412.html" rel="external">calculator 1</a> and <a class="calc calc_professional" href="/z/d/html/13415.html" rel="external">calculator 2</a>))</p><p class="bulletIndent2"><span class="glyph">•</span>Diabetes mellitus</p><p class="bulletIndent2"><span class="glyph">•</span>Chronic pulmonary diseases</p><p class="bulletIndent2"><span class="glyph">•</span>Sickle cell disease</p><p class="bulletIndent2"><span class="glyph">•</span>Immunosuppression</p><p class="bulletIndent2"><span class="glyph">•</span>Being unvaccinated or not being up-to-date on COVID-19 vaccination</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The clinical spectrum of SARS-CoV-2 infections in children ranges from asymptomatic to life-threatening. (See <a class="local">'Spectrum of disease severity'</a> above and <a class="local">'Severe disease in children'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The most common clinical findings in children are fever and cough. Other findings include shortness of breath, myalgia, rhinorrhea, headache, nausea/vomiting, abdominal pain, diarrhea, sore throat, fatigue, and loss of smell or taste. Although clinical deterioration may occur suddenly after approximately one week and should prompt urgent re-evaluation, most children recover within one to two weeks. (See <a class="local">'Clinical findings'</a> above and <a class="local">'Clinical course'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Complications of SARS-CoV-2 infection in children include multisystem inflammatory syndrome in children (MIS-C;  (<a class="graphic graphic_table graphicRef128294 graphicRef128201" href="/z/d/graphic/128294.html" rel="external">table 3A-B</a>)) and post-COVID-19 condition (persistent, recurrent, or novel physical or mental health symptoms that are present ≥4 weeks after SARS-CoV-2 infection). (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory findings</strong> – Laboratory findings are often normal but may include leukopenia, lymphocytopenia, and elevated procalcitonin or C-reactive protein. (See <a class="local">'Laboratory findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Criteria for testing</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Outpatient settings – In the emergency department, urgent care, or outpatient setting, we perform COVID-19 testing in children who (see <a class="local">'Outpatient testing criteria'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Have symptoms consistent with COVID-19 (eg, fever, cough, rhinorrhea, shortness of breath, vomiting, diarrhea, sore throat, body aches, fatigue, altered sense of smell or taste), independent of vaccination status, severity of symptoms, and risk for severe disease (see <a class="local">'Clinical findings'</a> above and <a class="local">'Risk factors for severe disease'</a> above)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Have clinical manifestations of MIS-C in children  (<a class="graphic graphic_table graphicRef128201" href="/z/d/graphic/128201.html" rel="external">table 3B</a>) (see  <a class="medical medical_review" href="/z/d/html/128190.html" rel="external">"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis", section on 'Clinical manifestations'</a>)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Have known in-person exposure to a <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fndc.services.cdc.gov%2Fcase-definitions%2Fcoronavirus-disease-2019-2021%2F&amp;token=d8oA%2F7NZfraiyYDWg3l0X2mjpXfnXiSaHPIr06VxIzF1KFHxfMik1%2Fl3kKXRr6s17AzHnnvCqkt00u9Y4AM3Dw53JdLUrYbZhkqCbXBWq%2FY%3D&amp;TOPIC_ID=127488" target="_blank">close contact</a> with laboratory-confirmed case of COVID-19 within the previous 14 days</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Develop recurrent symptoms two to eight days after completing treatment with <a class="drug drug_pediatric" data-topicid="134696" href="/z/d/drug information/134696.html" rel="external">nirmatrelvir-ritonavir</a></p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Require clearance to return to in-person school attendance after recovery from a symptomatic illness or asymptomatic, nonhousehold COVID-19 exposure</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hospitalized children – Testing children at the time of admission to the hospital may be beneficial when community transmission is high or in settings where other control measures are limited (eg, shared patient rooms, congregate care, behavioral health issues). Decisions regarding testing of asymptomatic children at the time of admission usually are made at the institutional level. (See <a class="local">'Inpatient testing criteria'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory tests and interpretation</strong> – Laboratory tests for COVID-19  (<a class="graphic graphic_table graphicRef128419" href="/z/d/graphic/128419.html" rel="external">table 5</a>) and interpretation of laboratory tests for COVID-19, including antigen tests  (<a class="graphic graphic_algorithm graphicRef134206" href="/z/d/graphic/134206.html" rel="external">algorithm 1</a>), are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">"COVID-19: Diagnosis", section on 'Antigen testing'</a> and  <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">"COVID-19: Diagnosis", section on 'NAAT (including RT-PCR)'</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:422.</a></li><li><a class="nounderline abstract_t">Posfay-Barbe KM, Wagner N, Gauthey M, et al. COVID-19 in Children and the Dynamics of Infection in Families. Pediatrics 2020; 146.</a></li><li><a class="nounderline abstract_t">Wu Q, Xing Y, Shi L, et al. Coinfection and Other Clinical Characteristics of COVID-19 in Children. Pediatrics 2020; 146.</a></li><li><a class="nounderline abstract_t">Zachariah P, Johnson CL, Halabi KC, et al. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York. JAMA Pediatr 2020; 174:e202430.</a></li><li><a class="nounderline abstract_t">Liguoro I, Pilotto C, Bonanni M, et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr 2020; 179:1029.</a></li><li><a class="nounderline abstract_t">Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine 2020; 24:100433.</a></li><li><a class="nounderline abstract_t">Chua GT, Wong JSC, Lam I, et al. Clinical Characteristics and Transmission of COVID-19 in Children and Youths During 3 Waves of Outbreaks in Hong Kong. JAMA Netw Open 2021; 4:e218824.</a></li><li><a class="nounderline abstract_t">Lee B, Raszka WV Jr. COVID-19 Transmission and Children: The Child Is Not to Blame. Pediatrics 2020; 146.</a></li><li><a class="nounderline abstract_t">Li W, Zhang B, Lu J, et al. Characteristics of Household Transmission of COVID-19. Clin Infect Dis 2020; 71:1943.</a></li><li><a class="nounderline abstract_t">Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis 2020; 20:911.</a></li><li><a class="nounderline abstract_t">Rosenberg ES, Dufort EM, Blog DS, et al. COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020. Clin Infect Dis 2020; 71:1953.</a></li><li><a class="nounderline abstract_t">Laws RL, Chancey RJ, Rabold EM, et al. Symptoms and Transmission of SARS-CoV-2 Among Children - Utah and Wisconsin, March-May 2020. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Grijalva CG, Rolfes MA, Zhu Y, et al. Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1631.</a></li><li><a class="nounderline abstract_t">Somekh E, Gleyzer A, Heller E, et al. The Role of Children in the Dynamics of Intra Family Coronavirus 2019 Spread in Densely Populated Area. Pediatr Infect Dis J 2020; 39:e202.</a></li><li><a class="nounderline abstract_t">Madewell ZJ, Yang Y, Longini IM Jr, et al. Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis. JAMA Netw Open 2021; 4:e2122240.</a></li><li><a class="nounderline abstract_t">Madewell ZJ, Yang Y, Longini IM Jr, et al. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis. JAMA Netw Open 2022; 5:e229317.</a></li><li><a class="nounderline abstract_t">Schwierzeck V, König JC, Kühn J, et al. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit. Clin Infect Dis 2020.</a></li><li><a class="nounderline abstract_t">Hains DS, Schwaderer AL, Carroll AE, et al. Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit. JAMA 2020; 323:2424.</a></li><li><a class="nounderline abstract_t">Krass P, Zimbrick-Rogers C, Iheagwara C, et al. COVID-19 Outbreak Among Adolescents at an Inpatient Behavioral Health Hospital. J Adolesc Health 2020; 67:612.</a></li><li><a class="nounderline abstract_t">Brown NE, Bryant-Genevier J, Bandy U, et al. Antibody Responses after Classroom Exposure to Teacher with Coronavirus Disease, March 2020. Emerg Infect Dis 2020; 26.</a></li><li><a class="nounderline abstract_t">Macartney K, Quinn HE, Pillsbury AJ, et al. Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study. Lancet Child Adolesc Health 2020; 4:807.</a></li><li class="breakAll">American Academy of Pediatrics. Critical Updates on COVID-19. COVID-19 interim guidance. COVID-19 Guidance for safe schools and promotion of in-person learning. services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-planning-considerations-return-to-in-person-education-in-schools/ (Accessed on September 14, 2022).</li><li><a class="nounderline abstract_t">Ke R, Martinez PP, Smith RL, et al. Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness. Nat Microbiol 2022; 7:640.</a></li><li><a class="nounderline abstract_t">Hurst JH, Heston SM, Chambers HN, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study. Clin Infect Dis 2021; 73:e2875.</a></li><li><a class="nounderline abstract_t">Chung E, Chow EJ, Wilcox NC, et al. Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting. JAMA Pediatr 2021; 175:e212025.</a></li><li><a class="nounderline abstract_t">Yonker LM, Boucau J, Regan J, et al. Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children. J Infect Dis 2021; 224:1821.</a></li><li><a class="nounderline abstract_t">Ochoa V, Díaz FE, Ramirez E, et al. Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads. J Infect Dis 2022; 225:392.</a></li><li><a class="nounderline abstract_t">McLean HQ, Grijalva CG, Hanson KE, et al. Household Transmission and Clinical Features of SARS-CoV-2 Infections. Pediatrics 2022; 149.</a></li><li><a class="nounderline abstract_t">Stein-Zamir C, Abramson N, Shoob H, et al. A large COVID-19 outbreak in a high school 10 days after schools' reopening, Israel, May 2020. Euro Surveill 2020; 25.</a></li><li><a class="nounderline abstract_t">Szablewski CM, Chang KT, McDaniel CJ, et al. SARS-CoV-2 Transmission Dynamics in a Sleep-Away Camp. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Chu VT, Yousaf AR, Chang K, et al. Household Transmission of SARS-CoV-2 from Children and Adolescents. N Engl J Med 2021; 385:954.</a></li><li><a class="nounderline abstract_t">Bhatt M, Plint AC, Tang K, et al. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study. CMAJ Open 2022; 10:E357.</a></li><li><a class="nounderline abstract_t">Okarska-Napierała M, Mańdziuk J, Kuchar E. SARS-CoV-2 Cluster in Nursery, Poland. Emerg Infect Dis 2021; 27.</a></li><li><a class="nounderline abstract_t">Lopez AS, Hill M, Antezano J, et al. Transmission Dynamics of COVID-19 Outbreaks Associated with Child Care Facilities - Salt Lake City, Utah, April-July 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1319.</a></li><li><a class="nounderline abstract_t">Qiu H, Wu J, Hong L, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis 2020; 20:689.</a></li><li><a class="nounderline abstract_t">Huff HV, Singh A. Asymptomatic Transmission During the Coronavirus Disease 2019 Pandemic and Implications for Public Health Strategies. Clin Infect Dis 2020; 71:2752.</a></li><li class="breakAll">World Health Organization. COVID-19 disease in children and adolescents. Scientific brief. September 29, 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Children_and_adolescents-2021.1 (Accessed on September 30, 2021).</li><li><a class="nounderline abstract_t">Mallapaty S. How do children spread the coronavirus? The science still isn't clear. Nature 2020; 581:127.</a></li><li><a class="nounderline abstract_t">Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann Intern Med 2021; 174:69.</a></li><li><a class="nounderline abstract_t">Kim J, Choe YJ, Lee J, et al. Role of children in household transmission of COVID-19. Arch Dis Child 2021; 106:709.</a></li><li><a class="nounderline abstract_t">Zhu Y, Bloxham CJ, Hulme KD, et al. A Meta-analysis on the Role of Children in Severe Acute Respiratory Syndrome Coronavirus 2 in Household Transmission Clusters. Clin Infect Dis 2021; 72:e1146.</a></li><li><a class="nounderline abstract_t">Soriano-Arandes A, Gatell A, Serrano P, et al. Household Severe Acute Respiratory Syndrome Coronavirus 2 Transmission and Children: A Network Prospective Study. Clin Infect Dis 2021; 73:e1261.</a></li><li><a class="nounderline abstract_t">Li F, Li YY, Liu MJ, et al. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. Lancet Infect Dis 2021; 21:617.</a></li><li><a class="nounderline abstract_t">Paul LA, Daneman N, Schwartz KL, et al. Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection. JAMA Pediatr 2021; 175:1151.</a></li><li><a class="nounderline abstract_t">Lee B, Raszka WV Jr. COVID-19 in Children: Looking Forward, Not Back. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Coffin SE, Rubin D. Yes, Children Can Transmit COVID, but We Need Not Fear. JAMA Pediatr 2021; 175:1110.</a></li><li><a class="nounderline abstract_t">Chen F, Tian Y, Zhang L, Shi Y. The role of children in household transmission of COVID-19: a systematic review and meta-analysis. Int J Infect Dis 2022; 122:266.</a></li><li><a class="nounderline abstract_t">Frutos AM, Kuan G, Lopez R, et al. Infection-Induced Immunity Is Associated With Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Decreased Infectivity. Clin Infect Dis 2023; 76:2126.</a></li><li><a class="nounderline abstract_t">Goldstein E, Lipsitch M, Cevik M. On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community. J Infect Dis 2021; 223:362.</a></li><li><a class="nounderline abstract_t">Danis K, Epaulard O, Bénet T, et al. Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020. Clin Infect Dis 2020; 71:825.</a></li><li><a class="nounderline abstract_t">Ehrhardt J, Ekinci A, Krehl H, et al. Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in May 2020, Baden-Württemberg, Germany. Euro Surveill 2020; 25.</a></li><li><a class="nounderline abstract_t">Otte Im Kampe E, Lehfeld AS, Buda S, et al. Surveillance of COVID-19 school outbreaks, Germany, March to August 2020. Euro Surveill 2020; 25.</a></li><li><a class="nounderline abstract_t">Yung CF, Kam KQ, Nadua KD, et al. Novel Coronavirus 2019 Transmission Risk in Educational Settings. Clin Infect Dis 2021; 72:1055.</a></li><li><a class="nounderline abstract_t">Gilliam WS, Malik AA, Shafiq M, et al. COVID-19 Transmission in US Child Care Programs. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Hobbs CV, Martin LM, Kim SS, et al. Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged &lt;18 Years - Mississippi, September-November 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1925.</a></li><li><a class="nounderline abstract_t">Leidman E, Duca LM, Omura JD, et al. COVID-19 Trends Among Persons Aged 0-24 Years - United States, March 1-December 12, 2020. MMWR Morb Mortal Wkly Rep 2021; 70:88.</a></li><li><a class="nounderline abstract_t">Peaper DR, Murdzek C, Oliveira CR, Murray TS. Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Children in a Large Regional US Health System During the Coronavirus Disease 2019 Pandemic. Pediatr Infect Dis J 2021; 40:175.</a></li><li><a class="nounderline abstract_t">Brandal LT, Ofitserova TS, Meijerink H, et al. Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020. Euro Surveill 2021; 26.</a></li><li><a class="nounderline abstract_t">Zimmerman KO, Akinboyo IC, Brookhart MA, et al. Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Falk A, Benda A, Falk P, et al. COVID-19 Cases and Transmission in 17 K-12 Schools - Wood County, Wisconsin, August 31-November 29, 2020. MMWR Morb Mortal Wkly Rep 2021; 70:136.</a></li><li><a class="nounderline abstract_t">Varma JK, Thamkittikasem J, Whittemore K, et al. COVID-19 Infections Among Students and Staff in New York City Public Schools. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Ulyte A, Radtke T, Abela IA, et al. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools. BMJ 2021; 372:n616.</a></li><li><a class="nounderline abstract_t">Hershow RB, Wu K, Lewis NM, et al. Low SARS-CoV-2 Transmission in Elementary Schools - Salt Lake County, Utah, December 3, 2020-January 31, 2021. MMWR Morb Mortal Wkly Rep 2021; 70:442.</a></li><li><a class="nounderline abstract_t">Dawson P, Worrell MC, Malone S, et al. Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020. MMWR Morb Mortal Wkly Rep 2021; 70:449.</a></li><li><a class="nounderline abstract_t">Doyle T, Kendrick K, Troelstrup T, et al. COVID-19 in Primary and Secondary School Settings During the First Semester of School Reopening - Florida, August-December 2020. MMWR Morb Mortal Wkly Rep 2021; 70:437.</a></li><li><a class="nounderline abstract_t">Zimmerman KO, Brookhart MA, Kalu IC, et al. Community SARS-CoV-2 Surge and Within-School Transmission. Pediatrics 2021; 148.</a></li><li><a class="nounderline abstract_t">Yin S, Barnes K, Fisher R, et al. COVID-19 Case Rates in Transitional Kindergarten Through Grade 12 Schools and in the Community - Los Angeles County, California, September 2020-March 2021. MMWR Morb Mortal Wkly Rep 2021; 70:1220.</a></li><li><a class="nounderline abstract_t">Irfan O, Muttalib F, Tang K, et al. Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis. Arch Dis Child 2021; 106:440.</a></li><li class="breakAll">CDC COVID data tracker. Demographic trends of COVID-19 cases and deaths in the US reported to the CDC. Available at: www.cdc.gov/covid-data-tracker/index.html#demographics (Accessed on February 22, 2023).</li><li><a class="nounderline abstract_t">Couture A, Lyons BC, Mehrotra ML, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020-May 2021. Open Forum Infect Dis 2022; 9:ofac044.</a></li><li><a class="nounderline abstract_t">Clarke KEN, Jones JM, Deng Y, et al. Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies - United States, September 2021-February 2022. MMWR Morb Mortal Wkly Rep 2022; 71:606.</a></li><li class="breakAll">American Academy of Pediatrics. Children and COVID-19: State-Level Data Report. Available at services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/ (Accessed on February 22, 2023).</li><li class="breakAll">COVID Data Tracker. Nationwide Commercial Lab Pediatric Antibody Seroprevalence. Available at: https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence (Accessed on February 01, 2023).</li><li><a class="nounderline abstract_t">Delahoy MJ, Ujamaa D, Taylor CA, et al. Comparison of Influenza and Coronavirus Disease 2019-Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021). Clin Infect Dis 2023; 76:e450.</a></li><li class="breakAll">COVID-NET. A weekly summary of US COVID-19 hospitaliztion data. Available at: gis.cdc.gov/grasp/COVIDNet/COVID19_5.html (Accessed on February 22, 2023).</li><li><a class="nounderline abstract_t">Marks KJ, Whitaker M, Anglin O, et al. Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022; 71:271.</a></li><li><a class="nounderline abstract_t">Shi DS, Whitaker M, Marks KJ, et al. Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022. MMWR Morb Mortal Wkly Rep 2022; 71:574.</a></li><li><a class="nounderline abstract_t">Hamid S, Woodworth K, Pham H, et al. COVID-19-Associated Hospitalizations Among U.S. Infants Aged &lt;6 Months - COVID-NET, 13 States, June 2021-August 2022. MMWR Morb Mortal Wkly Rep 2022; 71:1442.</a></li><li><a class="nounderline abstract_t">Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:759.</a></li><li><a class="nounderline abstract_t">Shane AL, Sato AI, Kao C, et al. A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children. J Pediatric Infect Dis Soc 2020; 9:596.</a></li><li><a class="nounderline abstract_t">Wanga V, Gerdes ME, Shi DS, et al. Characteristics and Clinical Outcomes of Children and Adolescents Aged &lt;18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep 2021; 70:1766.</a></li><li><a class="nounderline abstract_t">Beck A, Gandhi M. Adjudicating Reasons for Hospitalization Reveals That Severe Illness From COVID-19 in Children Is Rare. Hosp Pediatr 2021; 11:e159.</a></li><li><a class="nounderline abstract_t">Smith C, Odd D, Harwood R, et al. Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat Med 2022; 28:185.</a></li><li><a class="nounderline abstract_t">Bhopal SS, Bagaria J, Olabi B, Bhopal R. Children and young people remain at low risk of COVID-19 mortality. Lancet Child Adolesc Health 2021; 5:e12.</a></li><li><a class="nounderline abstract_t">Correction to Lancet Child Adolesc Health 2021; published online March 10. https://doi.org/10.1016/S2352-4642(21)00066-3. Lancet Child Adolesc Health 2021; 5:e18.</a></li><li><a class="nounderline abstract_t">Flaxman S, Whittaker C, Semenova E, et al. Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US. JAMA Netw Open 2023; 6:e2253590.</a></li><li class="breakAll">United States Centers for Disease Control and Pevention. Disparities in COVID-19-associated hospitalizations. https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/racial-ethnic-disparities/disparities-hospitalization.html (Accessed on June 01, 2022).</li><li><a class="nounderline abstract_t">Vicetti Miguel CP, Dasgupta-Tsinikas S, Lamb GS, et al. Race, Ethnicity, and Health Disparities in US Children With COVID-19: A Review of the Evidence and Recommendations for the Future. J Pediatric Infect Dis Soc 2022; 11:S132.</a></li><li><a class="nounderline abstract_t">Kim L, Whitaker M, O'Halloran A, et al. Hospitalization Rates and Characteristics of Children Aged &lt;18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1081.</a></li><li><a class="nounderline abstract_t">González-Dambrauskas S, Vásquez-Hoyos P, Camporesi A, et al. Pediatric Critical Care and COVID-19. Pediatrics 2020; 146.</a></li><li><a class="nounderline abstract_t">Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr 2020; 174:868.</a></li><li><a class="nounderline abstract_t">DeBiasi RL, Song X, Delaney M, et al. Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region. J Pediatr 2020; 223:199.</a></li><li><a class="nounderline abstract_t">Parri N, Magistà AM, Marchetti F, et al. Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks. Eur J Pediatr 2020; 179:1315.</a></li><li><a class="nounderline abstract_t">Chao JY, Derespina KR, Herold BC, et al. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City. J Pediatr 2020; 223:14.</a></li><li><a class="nounderline abstract_t">Swann OV, Holden KA, Turtle L, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ 2020; 370:m3249.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. Underlying medical conditions associated with higher risk for severe COVID-19: Information for healthcare providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html (Accessed on February 22, 2023).</li><li><a class="nounderline abstract_t">Williams N, Radia T, Harman K, et al. COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities. Eur J Pediatr 2021; 180:689.</a></li><li><a class="nounderline abstract_t">McCormick DW, Richardson LC, Young PR, et al. Deaths in Children and Adolescents Associated With COVID-19 and MIS-C in the United States. Pediatrics 2021; 148.</a></li><li><a class="nounderline abstract_t">Ward JL, Harwood R, Smith C, et al. Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year. Nat Med 2022; 28:193.</a></li><li><a class="nounderline abstract_t">Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health 2020; 4:653.</a></li><li><a class="nounderline abstract_t">Bixler D, Miller AD, Mattison CP, et al. SARS-CoV-2-Associated Deaths Among Persons Aged &lt;21 Years - United States, February 12-July 31, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1324.</a></li><li><a class="nounderline abstract_t">Chiotos K, Hayes M, Kimberlin DW, et al. Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2. J Pediatric Infect Dis Soc 2021; 10:34.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. People with certain medical conditions. Additional information on children and teens. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html#ChildrenAndTeens (Accessed on February 22, 2023).</li><li class="breakAll">National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. covid19treatmentguidelines.nih.gov/ (Accessed on March 06, 2023).</li><li><a class="nounderline abstract_t">Drouin O, Hepburn CM, Farrar DS, et al. Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020. CMAJ 2021; 193:E1483.</a></li><li><a class="nounderline abstract_t">Woodruff RC, Campbell AP, Taylor CA, et al. Risk Factors for Severe COVID-19 in Children. Pediatrics 2021.</a></li><li><a class="nounderline abstract_t">Sanna G, Serrau G, Bassareo PP, et al. Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur J Pediatr 2020; 179:1079.</a></li><li><a class="nounderline abstract_t">Alsaied T, Aboulhosn JA, Cotts TB, et al. Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease. J Am Heart Assoc 2020; 9:e017224.</a></li><li><a class="nounderline abstract_t">Sabatino J, Ferrero P, Chessa M, et al. COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey. J Clin Med 2020; 9.</a></li><li><a class="nounderline abstract_t">Ehwerhemuepha L, Roth B, Patel AK, et al. Association of Congenital and Acquired Cardiovascular Conditions With COVID-19 Severity Among Pediatric Patients in the US. JAMA Netw Open 2022; 5:e2211967.</a></li><li><a class="nounderline abstract_t">Liu E, Smyth RL, Li Q, et al. Guidelines for the prevention and management of children and adolescents with COVID-19. Eur J Pediatr 2022; 181:4019.</a></li><li><a class="nounderline abstract_t">Kompaniyets L, Agathis NT, Nelson JM, et al. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children. JAMA Netw Open 2021; 4:e2111182.</a></li><li><a class="nounderline abstract_t">Tripathi S, Christison AL, Levy E, et al. The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With COVID-19. Hosp Pediatr 2021; 11:e297.</a></li><li><a class="nounderline abstract_t">Rao S, Hurst JH, Zhao C, et al. Asthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents. Pediatrics 2022; 149.</a></li><li><a class="nounderline abstract_t">Heilbronner C, Berteloot L, Tremolieres P, et al. Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit. Br J Haematol 2020; 190:e21.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. Interim clinical considerations for COVID-19 treatment in outpatients. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/outpatient-treatment-overview.html (Accessed on February 22, 2023).</li><li><a class="nounderline abstract_t">Preston LE, Chevinsky JR, Kompaniyets L, et al. Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19. JAMA Netw Open 2021; 4:e215298.</a></li><li><a class="nounderline abstract_t">Marlais M, Wlodkowski T, Vivarelli M, et al. The severity of COVID-19 in children on immunosuppressive medication. Lancet Child Adolesc Health 2020; 4:e17.</a></li><li><a class="nounderline abstract_t">Turner D, Huang Y, Martín-de-Carpi J, et al. COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN. J Pediatr Gastroenterol Nutr 2020.</a></li><li><a class="nounderline abstract_t">Sengler C, Eulert S, Minden K, et al. Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany. RMD Open 2021; 7.</a></li><li><a class="nounderline abstract_t">Morello W, Vianello FA, Proverbio E, et al. COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area. Pediatr Nephrol 2022; 37:757.</a></li><li><a class="nounderline abstract_t">Calvo C, Udaondo C, Rheumatic Diseases EPICO-AEP Working Group. COVID-19 in Children With Rheumatic Diseases in the Spanish National Cohort EPICO-AEP. J Rheumatol 2021; 48:1190.</a></li><li><a class="nounderline abstract_t">Mukkada S, Bhakta N, Chantada GL, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol 2021; 22:1416.</a></li><li><a class="nounderline abstract_t">Haeusler GM, Ammann RA, Carlesse F, et al. SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients. Eur J Cancer 2021; 159:78.</a></li><li><a class="nounderline abstract_t">Millen GC, Arnold R, Cazier JB, et al. COVID-19 in children with haematological malignancies. Arch Dis Child 2022; 107:186.</a></li><li><a class="nounderline abstract_t">Ouldali N, Yang DD, Madhi F, et al. Factors Associated With Severe SARS-CoV-2 Infection. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Hobbs CV, Woodworth K, Young CC, et al. Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants. Pediatr Infect Dis J 2022; 41:e81.</a></li><li><a class="nounderline abstract_t">Newman AM, Jhaveri R, Patel AB, et al. Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients. J Pediatr 2021; 228:294.</a></li><li><a class="nounderline abstract_t">Ku JH, Levin MJ, Luo Y, et al. Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System. J Infect Dis 2022; 226:757.</a></li><li><a class="nounderline abstract_t">Wallace B, Chang D, Woodworth K, et al. Illness severity indicators in newborns by COVID-19 status in the United States, March-December 2020. J Perinatol 2022; 42:446.</a></li><li><a class="nounderline abstract_t">Yılmaz K, Şen V. Is vitamin D deficiency a risk factor for COVID-19 in children? Pediatr Pulmonol 2020; 55:3595.</a></li><li><a class="nounderline abstract_t">Rubin R. Sorting Out Whether Vitamin D Deficiency Raises COVID-19 Risk. JAMA 2021; 325:329.</a></li><li><a class="nounderline abstract_t">Li Y, Tong CH, Bare LA, Devlin JJ. Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults. JAMA Netw Open 2021; 4:e2111634.</a></li><li><a class="nounderline abstract_t">Wang L, Berger NA, Kaelber DC, et al. Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US. JAMA Pediatr 2022; 176:811.</a></li><li><a class="nounderline abstract_t">Butt AA, Dargham SR, Loka S, et al. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant. Clin Infect Dis 2022; 75:e361.</a></li><li><a class="nounderline abstract_t">Ben-Tov A, Lotan R, Gazit S, et al. Dynamics in COVID-19 symptoms during different waves of the pandemic among children infected with SARS-CoV-2 in the ambulatory setting. Eur J Pediatr 2022; 181:3309.</a></li><li><a class="nounderline abstract_t">Esper FP, Adhikari TM, Tu ZJ, et al. Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants. J Infect Dis 2023; 227:344.</a></li><li><a class="nounderline abstract_t">Edward PR, Lorenzo-Redondo R, Reyna ME, et al. Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study. J Pediatric Infect Dis Soc 2022; 11:440.</a></li><li><a class="nounderline abstract_t">Recher M, Leteurtre S, Javouhey E, et al. Risk of Admission to the Pediatric Intensive Care Unit for SARS-CoV-2 Delta and Omicron Infections. J Pediatric Infect Dis Soc 2023; 12:189.</a></li><li><a class="nounderline abstract_t">Forrest CB, Burrows EK, Mejias A, et al. Severity of Acute COVID-19 in Children &lt;18 Years Old March 2020 to December 2021. Pediatrics 2022; 149.</a></li><li><a class="nounderline abstract_t">Karron RA, Hetrich MK, Na YB, et al. Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household Members. JAMA Netw Open 2022; 5:e2227348.</a></li><li><a class="nounderline abstract_t">de Hoog MLA, Sluiter-Post JGC, Westerhof I, et al. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic. JAMA Netw Open 2022; 5:e2237522.</a></li><li><a class="nounderline abstract_t">Viner RM, Ward JL, Hudson LD, et al. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch Dis Child 2020.</a></li><li><a class="nounderline abstract_t">Halasa NB, Spieker AJ, Young CC, et al. Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children. Clin Infect Dis 2023; 76:e280.</a></li><li><a class="nounderline abstract_t">Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395:1033.</a></li><li><a class="nounderline abstract_t">Yonker LM, Shen K, Kinane TB. Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection. Pediatr Pulmonol 2020; 55:1085.</a></li><li><a class="nounderline abstract_t">Zimmermann P, Curtis N. Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection. Pediatr Infect Dis J 2022; 41:e36.</a></li><li><a class="nounderline abstract_t">Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics 2020; 145.</a></li><li><a class="nounderline abstract_t">Yonker LM, Neilan AM, Bartsch Y, et al. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses. J Pediatr 2020; 227:45.</a></li><li><a class="nounderline abstract_t">Brodin P. Why is COVID-19 so mild in children? Acta Paediatr 2020; 109:1082.</a></li><li><a class="nounderline abstract_t">Bunyavanich S, Do A, Vicencio A. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. JAMA 2020; 323:2427.</a></li><li><a class="nounderline abstract_t">Ng KW, Faulkner N, Cornish GH, et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science 2020; 370:1339.</a></li><li><a class="nounderline abstract_t">Cyranoski D. Why children avoid the worst coronavirus complications might lie in their arteries. Nature 2020; 582:324.</a></li><li><a class="nounderline abstract_t">Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child 2020.</a></li><li><a class="nounderline abstract_t">Pierce CA, Sy S, Galen B, et al. Natural mucosal barriers and COVID-19 in children. JCI Insight 2021; 6.</a></li><li><a class="nounderline abstract_t">Hurst JH, McCumber AW, Aquino JN, et al. Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults. Clin Infect Dis 2022; 75:e928.</a></li><li><a class="nounderline abstract_t">Hobbs CV, Khaitan A, Kirmse BM, Borkowsky W. COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes. Front Pediatr 2020; 8:593455.</a></li><li><a class="nounderline abstract_t">Dowling DJ, Levy O. Ontogeny of early life immunity. Trends Immunol 2014; 35:299.</a></li><li><a class="nounderline abstract_t">Darmawan DO, Gwal K, Goudy BD, et al. Vaping in today's pandemic: E-cigarette, or vaping, product use-associated lung injury mimicking COVID-19 in teenagers presenting with respiratory distress. SAGE Open Med Case Rep 2020; 8:2050313X20969590.</a></li><li><a class="nounderline abstract_t">Greenan-Barrett J, Ciurtin C. COVID-19 in Immunocompromised Children and Adolescents. Pediatr Infect Dis J 2022; 41:e424.</a></li><li><a class="nounderline abstract_t">Tseng FH, Yeh SH, Basiago K, et al. Is Acute Solid Food Aversion a Proxy for COVID-19-Related Olfactory and Gustatory Dysfunction? Pediatrics 2021.</a></li><li><a class="nounderline abstract_t">Venn AMR, Schmidt JM, Mullan PC. Pediatric croup with COVID-19. Am J Emerg Med 2021; 43:287.e1.</a></li><li><a class="nounderline abstract_t">Brewster RC, Parsons C, Laird-Gion J, et al. COVID-19-Associated Croup in Children. Pediatrics 2022; 149.</a></li><li><a class="nounderline abstract_t">Murata Y, Tomari K, Matsuoka T. Children With Croup and SARS-CoV-2 Infection During the Large Outbreak of Omicron. Pediatr Infect Dis J 2022; 41:e249.</a></li><li><a class="nounderline abstract_t">Martin B, DeWitt PE, Russell S, et al. Acute Upper Airway Disease in Children With the Omicron (B.1.1.529) Variant of SARS-CoV-2-A Report From the US National COVID Cohort Collaborative. JAMA Pediatr 2022; 176:819.</a></li><li><a class="nounderline abstract_t">Lefchak B, Nickel A, Lammers S, et al. Analysis of COVID-19-Related Croup and SARS-CoV-2 Variant Predominance in the US. JAMA Netw Open 2022; 5:e2220060.</a></li><li><a class="nounderline abstract_t">Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet 2022; 399:1618.</a></li><li><a class="nounderline abstract_t">Sharma S, Agha B, Delgado C, et al. Croup Associated With SARS-CoV-2: Pediatric Laryngotracheitis During the Omicron Surge. J Pediatric Infect Dis Soc 2022; 11:371.</a></li><li><a class="nounderline abstract_t">Tunҫ EM, Koid Jia Shin C, Usoro E, et al. Croup during the Coronavirus Disease 2019 Omicron Variant Surge. J Pediatr 2022; 247:147.</a></li><li><a class="nounderline abstract_t">Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020; 51:843.</a></li><li><a class="nounderline abstract_t">Moradveisi B, Ataee P, Ghaffarieh A, et al. Diarrhea as a Presenting Symptom of Coronavirus Disease 2019 in Children. Adv Biomed Res 2020; 9:35.</a></li><li><a class="nounderline abstract_t">Assa A, Benninga MA, Borrelli O, et al. Gastrointestinal Perspective of Coronavirus Disease 2019 in Children-An Updated Review. J Pediatr Gastroenterol Nutr 2021; 73:299.</a></li><li><a class="nounderline abstract_t">Lu X, Zhang L, Du H, et al. SARS-CoV-2 Infection in Children. N Engl J Med 2020; 382:1663.</a></li><li><a class="nounderline abstract_t">Xia W, Shao J, Guo Y, et al. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol 2020; 55:1169.</a></li><li><a class="nounderline abstract_t">Wang D, Ju XL, Xie F, et al. [Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China]. Zhonghua Er Ke Za Zhi 2020; 58:269.</a></li><li><a class="nounderline abstract_t">Perez A, Kogan-Liberman D, Sheflin-Findling S, et al. Presentation of Severe Acute Respiratory Syndrome-Coronavirus 2 Infection as Cholestatic Jaundice in Two Healthy Adolescents. J Pediatr 2020; 226:278.</a></li><li><a class="nounderline abstract_t">Samies NL, Yarbrough A, Boppana S. Pancreatitis in Pediatric Patients With COVID-19. J Pediatric Infect Dis Soc 2021; 10:57.</a></li><li><a class="nounderline abstract_t">Paz L, Eslava E, Ribes M, Mayer EF. Acute Pancreatitis in a Teenager With SARS-CoV-2 Infection. Pediatr Infect Dis J 2021; 40:e161.</a></li><li><a class="nounderline abstract_t">Brisca G, Mallamaci M, Tardini G, et al. SARS-CoV-2 Infection May Present as Acute Hepatitis in Children. Pediatr Infect Dis J 2021; 40:e214.</a></li><li class="breakAll">World Health Organization. Multi-Country – Acute, severe hepatitis of unknown origin in children. 2022. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON376 (Accessed on April 26, 2022).</li><li><a class="nounderline abstract_t">Marsh K, Tayler R, Pollock L, et al. Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022. Euro Surveill 2022; 27.</a></li><li><a class="nounderline abstract_t">Antala S, Diamond T, Kociolek LK, et al. Severe Hepatitis in Pediatric Coronavirus Disease 2019. J Pediatr Gastroenterol Nutr 2022; 74:631.</a></li><li><a class="nounderline abstract_t">Corso CM, Marchisio P, Agostoni C, et al. Frequency of SARS-CoV-2 Positivity Among Children Presenting With Gastroenteritis in Emergency Department. Pediatr Infect Dis J 2023; 42:e38.</a></li><li><a class="nounderline abstract_t">Antoon JW, Hall M, Howard LM, et al. COVID-19 and Acute Neurologic Complications in Children. Pediatrics 2022; 150.</a></li><li><a class="nounderline abstract_t">Fink EL, Robertson CL, Wainwright MS, et al. Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C. Pediatr Neurol 2022; 128:33.</a></li><li><a class="nounderline abstract_t">LaRovere KL, Riggs BJ, Poussaint TY, et al. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol 2021; 78:536.</a></li><li><a class="nounderline abstract_t">LaRovere KL, Poussaint TY, Young CC, et al. Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020. JAMA Neurol 2023; 80:91.</a></li><li><a class="nounderline abstract_t">Deb N, Roy P, Biswakarma A, et al. Neurological Manifestations of Coronavirus Disease 2019 and Mpox in Pediatric Patients and Their Management: A State-of-the-Art Systematic Review. Pediatr Neurol 2023; 146:65.</a></li><li><a class="nounderline abstract_t">Iijima H, Kubota M, Ogimi C. Change in Seizure Incidence in Febrile Children With COVID-19 in the Era of Omicron Variant of Concern. J Pediatric Infect Dis Soc 2022; 11:514.</a></li><li><a class="nounderline abstract_t">Parri N, Lenge M, Buonsenso D, Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med 2020; 383:187.</a></li><li><a class="nounderline abstract_t">Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183:71.</a></li><li><a class="nounderline abstract_t">Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020; 34:e212.</a></li><li><a class="nounderline abstract_t">Manalo IF, Smith MK, Cheeley J, Jacobs R. A dermatologic manifestation of COVID-19: Transient livedo reticularis. J Am Acad Dermatol 2020; 83:700.</a></li><li><a class="nounderline abstract_t">Rotulo GA, Signa S, Rosina S, et al. Giant Urticaria and Acral Peeling in a Child with Coronavirus Disease 2019. J Pediatr 2021; 230:261.</a></li><li><a class="nounderline abstract_t">Ma N, Li P, Wang X, et al. Ocular Manifestations and Clinical Characteristics of Children With Laboratory-Confirmed COVID-19 in Wuhan, China. JAMA Ophthalmol 2020; 138:1079.</a></li><li><a class="nounderline abstract_t">Samuel S, Friedman RA, Sharma C, et al. Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval. Heart Rhythm 2020; 17:1960.</a></li><li><a class="nounderline abstract_t">Simpson M, Collins C, Nash DB, et al. Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease. J Pediatr 2020; 227:302.</a></li><li><a class="nounderline abstract_t">Dimopoulou D, Spyridis N, Dasoula F, et al. Pericarditis as the Main Clinical Manifestation of COVID-19 in Adolescents. Pediatr Infect Dis J 2021; 40:e197.</a></li><li><a class="nounderline abstract_t">Wu L, O'Kane AM, Peng H, et al. SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management. Biochem Pharmacol 2020; 178:114114.</a></li><li><a class="nounderline abstract_t">Panjabi AL, Foster RC, McCarthy AM, et al. Pulmonary Embolism as the Initial Presentation of Coronavirus Disease 2019 in Adolescents. Pediatr Infect Dis J 2021; 40:e200.</a></li><li><a class="nounderline abstract_t">Chima M, Williams D, Thomas NJ, Krawiec C. COVID-19-Associated Pulmonary Embolism in Pediatric Patients. Hosp Pediatr 2021; 11:e90.</a></li><li><a class="nounderline abstract_t">Persson J, Shorofsky M, Leahy R, et al. ST-Elevation Myocardial Infarction due to Acute Thrombosis in an Adolescent With COVID-19. Pediatrics 2021; 148.</a></li><li><a class="nounderline abstract_t">Boehmer TK, Kompaniyets L, Lavery AM, et al. Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021. MMWR Morb Mortal Wkly Rep 2021; 70:1228.</a></li><li><a class="nounderline abstract_t">Raina R, Mawby I, Chakraborty R, et al. Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data. PLoS One 2022; 17:e0266737.</a></li><li><a class="nounderline abstract_t">Stewart DJ, Hartley JC, Johnson M, et al. Renal dysfunction in hospitalised children with COVID-19. Lancet Child Adolesc Health 2020; 4:e28.</a></li><li><a class="nounderline abstract_t">Mark EG, Golden WC, Gilmore MM, et al. Community-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Young Infants: A Systematic Review. J Pediatr 2021; 228:94.</a></li><li><a class="nounderline abstract_t">Akin IM, Kanburoglu MK, Tayman C, et al. Epidemiologic and clinical characteristics of neonates with late-onset COVID-19: 1-year data of Turkish Neonatal Society. Eur J Pediatr 2022; 181:1933.</a></li><li><a class="nounderline abstract_t">Ng KF, Bandi S, Bird PW, Wei-Tze Tang J. COVID-19 in Neonates and Infants: Progression and Recovery. Pediatr Infect Dis J 2020; 39:e140.</a></li><li><a class="nounderline abstract_t">Piché-Renaud PP, Panetta L, Farrar DS, et al. Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada. PLoS One 2022; 17:e0272648.</a></li><li><a class="nounderline abstract_t">Leibowitz J, Krief W, Barone S, et al. Comparison of Clinical and Epidemiologic Characteristics of Young Febrile Infants with and without Severe Acute Respiratory Syndrome Coronavirus-2 Infection. J Pediatr 2021; 229:41.</a></li><li><a class="nounderline abstract_t">Blázquez-Gamero D, Epalza C, Cadenas JAA, et al. Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old. Eur J Pediatr 2021; 180:2099.</a></li><li><a class="nounderline abstract_t">Paret M, Lalani K, Hedari C, et al. SARS-CoV-2 Among Infants &lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation. Pediatrics 2021; 148.</a></li><li><a class="nounderline abstract_t">Scottoni F, Giobbe GG, Zambaiti E, et al. Intussusception and COVID-19 in Infants: Evidence for an Etiopathologic Correlation. Pediatrics 2022; 149.</a></li><li><a class="nounderline abstract_t">Grimaud E, Challiol M, Guilbaud C, et al. Delayed acute bronchiolitis in infants hospitalized for COVID-19. Pediatr Pulmonol 2020; 55:2211.</a></li><li><a class="nounderline abstract_t">André MC, Pätzug K, Bielicki J, et al. Can SARS-CoV-2 cause life-threatening bronchiolitis in infants? Pediatr Pulmonol 2020; 55:2842.</a></li><li><a class="nounderline abstract_t">Krajcar N, Marić LS, Roglić S, Tešović G. Among Young Infants With Uncomplicated COVID-19: Should We Broaden Diagnostic Tests for Infectious Causes of Apnea? Pediatr Infect Dis J 2022; 41:e301.</a></li><li><a class="nounderline abstract_t">Vanhems P, Endtz H, Dananché C, et al. Comparison of the Clinical Features of SARS-CoV-2, Other Coronavirus and Influenza Infections in Infants Less Than 1-Year-Old. Pediatr Infect Dis J 2020; 39:e157.</a></li><li><a class="nounderline abstract_t">Feldstein LR, Tenforde MW, Friedman KG, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA 2021; 325:1074.</a></li><li><a class="nounderline abstract_t">Devin J, Marano R, Mikhael M, et al. Epidemiology of Neonatal COVID-19 in the United States. Pediatrics 2022; 150.</a></li><li><a class="nounderline abstract_t">Boly TJ, Reyes-Hernandez ME, Daniels EC, et al. Hyperglycemia and Cytopenias as Signs of SARS-CoV-2 Delta Variant Infection in Preterm Infants. Pediatrics 2022; 149.</a></li><li><a class="nounderline abstract_t">Bailey LC, Razzaghi H, Burrows EK, et al. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. JAMA Pediatr 2021; 175:176.</a></li><li><a class="nounderline abstract_t">Martin B, DeWitt PE, Russell S, et al. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative. JAMA Netw Open 2022; 5:e2143151.</a></li><li><a class="nounderline abstract_t">Gonzalez Jimenez D, Velasco Rodríguez-Belvís M, Ferrer Gonzalez P, et al. COVID-19 Gastrointestinal Manifestations Are Independent Predictors of PICU Admission in Hospitalized Pediatric Patients. Pediatr Infect Dis J 2020; 39:e459.</a></li><li><a class="nounderline abstract_t">Fernandes DM, Oliveira CR, Guerguis S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth. J Pediatr 2021; 230:23.</a></li><li><a class="nounderline abstract_t">Zhou B, Yuan Y, Wang S, et al. Risk profiles of severe illness in children with COVID-19: a meta-analysis of individual patients. Pediatr Res 2021; 90:347.</a></li><li><a class="nounderline abstract_t">Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health 2021; 5:708.</a></li><li><a class="nounderline abstract_t">Gandhi RT, Lynch JB, Del Rio C. Mild or Moderate Covid-19. N Engl J Med 2020; 383:1757.</a></li><li class="breakAll">American Academy of Pediatrics. Critical Updates on COVID-19. COVID-19 interim guidance. Post-COVID-19 conditions in children and adolescents. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/post-covid-19-conditions-in-children-and-adolescents/ (Accessed on October 06, 2022).</li><li class="breakAll">United States Centers for Disease Control and Prevention. COVID-19. Post-COVID conditions: Information for healthcare providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-index.html (Accessed on January 12, 2023).</li><li class="breakAll">World Health Organization. A clinical case definition of post COVID-19 condition in children and adolescents by expert consensus, 16 February 2023. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1 (Accessed on February 21, 2023).</li><li><a class="nounderline abstract_t">Zimmermann P, Pittet LF, Curtis N. How Common is Long COVID in Children and Adolescents? Pediatr Infect Dis J 2021; 40:e482.</a></li><li><a class="nounderline abstract_t">Pellegrino R, Chiappini E, Licari A, et al. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr 2022; 181:3995.</a></li><li><a class="nounderline abstract_t">Maddux AB, Berbert L, Young CC, et al. Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C. Pediatrics 2022; 150.</a></li><li><a class="nounderline abstract_t">Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J 2022; 59.</a></li><li><a class="nounderline abstract_t">Funk AL, Kuppermann N, Florin TA, et al. Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection. JAMA Netw Open 2022; 5:e2223253.</a></li><li><a class="nounderline abstract_t">Doshi JA, Sheils NE, Buresh J, et al. SARS-CoV-2 Sequelae and Postdischarge Health Care Visits Over 5 Months Follow-up Among Children Hospitalized for COVID-19 or MIS-C. Pediatr Infect Dis J 2022; 41:e513.</a></li><li><a class="nounderline abstract_t">Bygdell M, Kindblom JM, Martikainen J, et al. Incidence and Characteristics in Children with Post-COVID-19 Condition in Sweden. JAMA Netw Open 2023; 6:e2324246.</a></li><li><a class="nounderline abstract_t">Rao S, Lee GM, Razzaghi H, et al. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. JAMA Pediatr 2022; 176:1000.</a></li><li><a class="nounderline abstract_t">Zimmermann P, Pittet LF, Curtis N. The Challenge of Studying Long COVID: An Updated Review. Pediatr Infect Dis J 2022; 41:424.</a></li><li><a class="nounderline abstract_t">Zimmermann P, Pittet LF, Curtis N. Long covid in children and adolescents. BMJ 2022; 376:o143.</a></li><li><a class="nounderline abstract_t">Messiah SE, Hao T, DeSantis SM, et al. Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents. Pediatr Infect Dis J 2022; 41:e409.</a></li><li><a class="nounderline abstract_t">Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents. JAMA 2021.</a></li><li><a class="nounderline abstract_t">Leftin Dobkin SC, Collaco JM, McGrath-Morrow SA. Protracted respiratory findings in children post-SARS-CoV-2 infection. Pediatr Pulmonol 2021; 56:3682.</a></li><li><a class="nounderline abstract_t">Stephenson T, Pinto Pereira SM, Shafran R, et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health 2022; 6:230.</a></li><li><a class="nounderline abstract_t">Borch L, Holm M, Knudsen M, et al. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr 2022; 181:1597.</a></li><li><a class="nounderline abstract_t">Kompaniyets L, Bull-Otterson L, Boehmer TK, et al. Post-COVID-19 Symptoms and Conditions Among Children and Adolescents - United States, March 1, 2020-January 31, 2022. MMWR Morb Mortal Wkly Rep 2022; 71:993.</a></li><li><a class="nounderline abstract_t">Taquet M, Sillett R, Zhu L, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry 2022; 9:815.</a></li><li><a class="nounderline abstract_t">Roessler M, Tesch F, Batram M, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med 2022; 19:e1004122.</a></li><li><a class="nounderline abstract_t">Heiss R, Tan L, Schmidt S, et al. Pulmonary Dysfunction after Pediatric COVID-19. Radiology 2023; 306:e221250.</a></li><li><a class="nounderline abstract_t">Jiang L, Li X, Nie J, et al. A Systematic Review of Persistent Clinical Features After SARS-CoV-2 in the Pediatric Population. Pediatrics 2023; 152.</a></li><li><a class="nounderline abstract_t">Drogalis-Kim D, Kramer C, Duran S. Ongoing Dizziness Following Acute COVID-19 Infection: A Single Center Pediatric Case Series. Pediatrics 2022; 150.</a></li><li><a class="nounderline abstract_t">Sorg AL, Becht S, Jank M, et al. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany. JAMA Netw Open 2022; 5:e2233454.</a></li><li><a class="nounderline abstract_t">Pinto Pereira SM, Shafran R, Nugawela MD, et al. Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months. Lancet Reg Health Eur 2023; 25:100554.</a></li><li><a class="nounderline abstract_t">Tartof SY, Malden DE, Liu IA, et al. Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection. JAMA Netw Open 2022; 5:e2225657.</a></li><li><a class="nounderline abstract_t">Hu Z, Song C, Xu C, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci 2020; 63:706.</a></li><li><a class="nounderline abstract_t">Wang Y, Liu Y, Liu L, et al. Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China. J Infect Dis 2020; 221:1770.</a></li><li><a class="nounderline abstract_t">Shelmerdine SC, Lovrenski J, Caro-Domínguez P, et al. Coronavirus disease 2019 (COVID-19) in children: a systematic review of imaging findings. Pediatr Radiol 2020; 50:1217.</a></li><li><a class="nounderline abstract_t">Nino G, Zember J, Sanchez-Jacob R, et al. Pediatric lung imaging features of COVID-19: A systematic review and meta-analysis. Pediatr Pulmonol 2021; 56:252.</a></li><li><a class="nounderline abstract_t">Rostad BS, Shah JH, Rostad CA, et al. Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19. Pediatr Radiol 2021; 51:231.</a></li><li><a class="nounderline abstract_t">Denina M, Scolfaro C, Silvestro E, et al. Lung Ultrasound in Children With COVID-19. Pediatrics 2020; 146.</a></li><li><a class="nounderline abstract_t">King JA, Whitten TA, Bakal JA, McAlister FA. Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta. CMAJ 2021; 193:E1.</a></li><li><a class="nounderline abstract_t">Poline J, Gaschignard J, Leblanc C, et al. Systematic Severe Acute Respiratory Syndrome Coronavirus 2 Screening at Hospital Admission in Children: A French Prospective Multicenter Study. Clin Infect Dis 2021; 72:2215.</a></li><li><a class="nounderline abstract_t">Ristagno EH, Bryant KA. Coronavirus Disease 2019 (COVID-19) and Children: Adding Another Piece to the Puzzle. Clin Infect Dis 2021; 72:2218.</a></li><li><a class="nounderline abstract_t">Wald ER, Schmit KM, Gusland DY. A Pediatric Infectious Disease Perspective on COVID-19. Clin Infect Dis 2021; 72:1660.</a></li><li><a class="nounderline abstract_t">Jimenez-García R, Nogueira J, Retuerta-Oliva A, et al. Pneumonia in Hospitalized Children During SARS-CoV-2 Pandemic. Is it All COVID-19? Comparison Between COVID and Non-COVID Pneumonia. Pediatr Infect Dis J 2021; 40:e111.</a></li><li><a class="nounderline abstract_t">Chung JR, Kim SS, Jackson ML, et al. Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2. Open Forum Infect Dis 2021; 8:ofaa576.</a></li><li><a class="nounderline abstract_t">Struyf T, Deeks JJ, Dinnes J, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev 2022; 5:CD013665.</a></li><li class="breakAll">Centers for Disease Control and Prevention. COVID-19. Overview of Testing for SARS-CoV-2, the virus that causes COVID-19. www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html (Accessed on October 06, 2022).</li><li class="breakAll">Infectious Diseases Society of America. COVID-19 Prioritization of Diagnostic Testing. https://www.idsociety.org/globalassets/idsa/public-health/covid-19-prioritization-of-dx-testing.pdf (Accessed on March 22, 2020).</li><li class="breakAll">American Academy of Pediatrics. Critical Updates on COVID-19. COVID-19 Interim Guidance. COVID-19 Testing Guidance. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-testing-guidance/ (Accessed on January 12, 2023).</li><li><a class="nounderline abstract_t">Talbot TR, Hayden MK, Yokoe DS, et al. Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations. Infect Control Hosp Epidemiol 2023; 44:2.</a></li><li><a class="nounderline abstract_t">Fujita-Rohwerder N, Beckmann L, Zens Y, Verma A. Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysis. BMJ Evid Based Med 2022; 27:274.</a></li><li><a class="nounderline abstract_t">Wolters F, Grünberg M, Huber M, et al. European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test. J Med Virol 2021; 93:5798.</a></li><li><a class="nounderline abstract_t">Mboumba Bouassa RS, Tonen-Wolyec S, Veyer D, et al. Analytical performances of the AMPLIQUICK® Respiratory Triplex assay for simultaneous detection and differentiation of SARS-CoV-2, influenza A/B and respiratory syncytial viruses in respiratory specimens. PLoS One 2022; 17:e0262258.</a></li><li><a class="nounderline abstract_t">Cheng A, Riedel S, Arnaout R, Kirby JE. Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus. Diagn Microbiol Infect Dis 2022; 102:115575.</a></li><li><a class="nounderline abstract_t">Kim TY, Kim JY, Shim HJ, et al. Comparison of the PowerChek SARS-CoV-2, Influenza A&amp;B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus. J Virol Methods 2021; 298:114304.</a></li><li class="breakAll">US Food and Drug Administration. FDA news release. Coronavirus (COVID-19) update: FDA authorizes first COVID-19 test available without a prescription that also detects flu and RSV. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-covid-19-test-available-without-prescription-also (Accessed on May 23, 2022).</li><li><a class="nounderline abstract_t">Song X, Delaney M, Shah RK, et al. Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children. JAMA Netw Open 2020; 3:e2020495.</a></li><li><a class="nounderline abstract_t">Adams K, Tastad KJ, Huang S, et al. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged &lt;18 Years Who Were Hospitalized or Died with Influenza - United States, 2021-22 Influenza Season. MMWR Morb Mortal Wkly Rep 2022; 71:1589.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Health Alert Network. Severe Respiratory Illnesses Associated with Rhinoviruses and/or Enteroviruses Including EV-D68 – Multistate, 2022. Available at: https://emergency.cdc.gov/han/2022/han00474.asp (Accessed on September 14, 2022).</li><li><a class="nounderline abstract_t">Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020; 323:2052.</a></li><li><a class="nounderline abstract_t">Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China. Emerg Infect Dis 2020; 26:1324.</a></li><li><a class="nounderline abstract_t">Ding Q, Lu P, Fan Y, et al. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol 2020; 92:1549.</a></li><li><a class="nounderline abstract_t">Pongpirul WA, Mott JA, Woodring JV, et al. Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand. Emerg Infect Dis 2020; 26:1580.</a></li><li><a class="nounderline abstract_t">Kim D, Quinn J, Pinsky B, et al. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA 2020; 323:2085.</a></li><li><a class="nounderline abstract_t">Alvares PA. SARS-CoV-2 and Respiratory Syncytial Virus Coinfection in Hospitalized Pediatric Patients. Pediatr Infect Dis J 2021; 40:e164.</a></li><li><a class="nounderline abstract_t">Raissaki M, Shelmerdine SC, Damasio MB, et al. Management strategies for children with COVID-19: ESPR practical recommendations. Pediatr Radiol 2020; 50:1313.</a></li><li><a class="nounderline abstract_t">Caro-Dominguez P, Shelmerdine SC, Toso S, et al. Thoracic imaging of coronavirus disease 2019 (COVID-19) in children: a series of 91 cases. Pediatr Radiol 2020; 50:1354.</a></li></ol></div><div id="topicVersionRevision">Topic 127488 Version 143.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32271728" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32457213" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : COVID-19 in Children and the Dynamics of Infection in Families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32376725" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Coinfection and Other Clinical Characteristics of COVID-19 in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32492092" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32424745" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : SARS-COV-2 infection in children and newborns: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32766542" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : COVID-19 in 7780 pediatric patients: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33938934" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical Characteristics and Transmission of COVID-19 in Children and Youths During 3 Waves of Outbreaks in Hong Kong.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32457212" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : COVID-19 Transmission and Children: The Child Is Not to Blame.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32301964" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Characteristics of Household Transmission of COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32353347" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32382743" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33033178" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Symptoms and Transmission of SARS-CoV-2 Among Children - Utah and Wisconsin, March-May 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33151916" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32496407" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The Role of Children in the Dynamics of Intra Family Coronavirus 2019 Spread in Densely Populated Area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34448865" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35482308" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32337584" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32407440" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32798098" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : COVID-19 Outbreak Among Adolescents at an Inpatient Behavioral Health Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32597750" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Antibody Responses after Classroom Exposure to Teacher with Coronavirus Disease, March 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32758454" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32758454" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35484231" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33141180" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Severe Acute Respiratory Syndrome Coronavirus 2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34115094" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34647601" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34850028" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35194642" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Household Transmission and Clinical Features of SARS-CoV-2 Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32720636" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A large COVID-19 outbreak in a high school 10 days after schools' reopening, Israel, May 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33504612" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : SARS-CoV-2 Transmission Dynamics in a Sleep-Away Camp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34289272" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Household Transmission of SARS-CoV-2 from Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35414597" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33035153" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : SARS-CoV-2 Cluster in Nursery, Poland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32941418" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Transmission Dynamics of COVID-19 Outbreaks Associated with Child Care Facilities - Salt Lake City, Utah, April-July 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32220650" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32463076" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Asymptomatic Transmission During the Coronavirus Disease 2019 Pandemic and Implications for Public Health Strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32463076" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Asymptomatic Transmission During the Coronavirus Disease 2019 Pandemic and Implications for Public Health Strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32382119" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : How do children spread the coronavirus? The science still isn't clear.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32941052" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32769089" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Role of children in household transmission of COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33283240" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A Meta-analysis on the Role of Children in Severe Acute Respiratory Syndrome Coronavirus 2 in Household Transmission Clusters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33709135" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Household Severe Acute Respiratory Syndrome Coronavirus 2 Transmission and Children: A Network Prospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33476567" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34398179" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33033179" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : COVID-19 in Children: Looking Forward, Not Back.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34398229" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Yes, Children Can Transmit COVID, but We Need Not Fear.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35562045" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The role of children in household transmission of COVID-19: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36774538" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Infection-Induced Immunity Is Associated With Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Decreased Infectivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33119738" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32277759" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32914746" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in May 2020, Baden-Württemberg, Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32975186" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Surveillance of COVID-19 school outbreaks, Germany, March to August 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32584975" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Novel Coronavirus 2019 Transmission Risk in Educational Settings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33055228" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : COVID-19 Transmission in US Child Care Programs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33332298" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged&lt;18 Years - Mississippi, September-November 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33476314" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : COVID-19 Trends Among Persons Aged 0-24 Years - United States, March 1-December 12, 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33399431" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Children in a Large Regional US Health System During the Coronavirus Disease 2019 Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33413743" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33419869" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33507890" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : COVID-19 Cases and Transmission in 17 K-12 Schools - Wood County, Wisconsin, August 31-November 29, 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33688033" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : COVID-19 Infections Among Students and Staff in New York City Public Schools.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33731327" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33764967" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Low SARS-CoV-2 Transmission in Elementary Schools - Salt Lake County, Utah, December 3, 2020-January 31, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33764961" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33764962" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : COVID-19 in Primary and Secondary School Settings During the First Semester of School Reopening - Florida, August-December 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34321339" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Community SARS-CoV-2 Surge and Within-School Transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34473679" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : COVID-19 Case Rates in Transitional Kindergarten Through Grade 12 Schools and in the Community - Los Angeles County, California, September 2020-March 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33593743" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33593743" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35198651" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020-May 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35482574" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies - United States, September 2021-February 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35482574" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies - United States, September 2021-February 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35482574" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies - United States, September 2021-February 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35594564" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Comparison of Influenza and Coronavirus Disease 2019-Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35594564" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Comparison of Influenza and Coronavirus Disease 2019-Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35176003" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, July 2021-January 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35446827" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36355608" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : COVID-19-Associated Hospitalizations Among U.S. Infants Aged&lt;6 Months - COVID-NET, 13 States, June 2021-August 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32555134" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32840614" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34968374" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Characteristics and Clinical Outcomes of Children and Adolescents Aged&lt;18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34011568" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Adjudicating Reasons for Hospitalization Reveals That Severe Illness From COVID-19 in Children Is Rare.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34764489" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33713603" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Children and young people remain at low risk of COVID-19 mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33773108" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Correction to Lancet Child Adolesc Health 2021; published online March 10. https://doi.org/10.1016/S2352-4642(21)00066-3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36716029" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36716029" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36063366" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Race, Ethnicity, and Health Disparities in US Children With COVID-19: A Review of the Evidence and Recommendations for the Future.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32790664" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Hospitalization Rates and Characteristics of Children Aged&lt;18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32518171" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Pediatric Critical Care and COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32392288" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32405091" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32495147" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32407719" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32960186" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32960186" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32914200" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34385349" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Deaths in Children and Adolescents Associated With COVID-19 and MIS-C in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34931076" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32593339" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32941417" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : SARS-CoV-2-Associated Deaths Among Persons Aged&lt;21 Years - United States, February 12-July 31, 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32918548" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32918548" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32918548" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34580141" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34686570" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Risk Factors for Severe COVID-19 in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32474800" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32441586" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32521643" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35579899" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Association of Congenital and Acquired Cardiovascular Conditions With COVID-19 Severity Among Pediatric Patients in the US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36109390" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Guidelines for the prevention and management of children and adolescents with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34097050" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34168067" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35274143" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Asthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32420608" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32420608" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33835179" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Characteristics and Disease Severity of US Children and Adolescents Diagnosed With COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32411815" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : The severity of COVID-19 in children on immunosuppressive medication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32235161" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34312307" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34687377" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33526617" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : COVID-19 in Children With Rheumatic Diseases in the Spanish National Cohort EPICO-AEP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34454651" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34736044" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34301621" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : COVID-19 in children with haematological malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33323493" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Factors Associated With Severe SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34955519" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32861693" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35749312" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34728822" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Illness severity indicators in newborns by COVID-19 status in the United States, March-December 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33017102" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Is vitamin D deficiency a risk factor for COVID-19 in children?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33404587" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Sorting Out Whether Vitamin D Deficiency Raises COVID-19 Risk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34009346" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35363246" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35404391" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35778524" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Dynamics in COVID-19 symptoms during different waves of the pandemic among children infected with SARS-CoV-2 in the ambulatory setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36214810" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35924454" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36786499" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Risk of Admission to the Pediatric Intensive Care Unit for SARS-CoV-2 Delta and Omicron Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35322270" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Severity of Acute COVID-19 in Children&lt;18 Years Old March 2020 to December 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36044218" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household Members.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36264578" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33334728" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35717646" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32192578" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : COVID-19: consider cytokine storm syndromes and immunosuppression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32243722" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Lessons unfolding from pediatric cases of COVID-19 disease caused by SARS-CoV-2 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34966142" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32179660" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Epidemiology of COVID-19 Among Children in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32827525" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32212348" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Why is COVID-19 so mild in children?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32432657" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33159009" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32546867" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Why children avoid the worst coronavirus complications might lie in their arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33262177" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33822777" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Natural mucosal barriers and COVID-19 in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35247047" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33330288" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24880460" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Ontogeny of early life immunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33194204" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Vaping in today's pandemic: E-cigarette, or vaping, product use-associated lung injury mimicking COVID-19 in teenagers presenting with respiratory distress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35703274" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : COVID-19 in Immunocompromised Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34654753" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Is Acute Solid Food Aversion a Proxy for COVID-19-Related Olfactory and Gustatory Dysfunction?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32980228" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Pediatric croup with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35257175" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : COVID-19-Associated Croup in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35185142" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Children With Croup and SARS-CoV-2 Infection During the Large Outbreak of Omicron.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35426941" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Acute Upper Airway Disease in Children With the Omicron (B.1.1.529) Variant of SARS-CoV-2-A Report From the US National COVID Cohort Collaborative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35796213" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Analysis of COVID-19-Related Croup and SARS-CoV-2 Variant Predominance in the US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35397851" id="rid166" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>167 : Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35512450" id="rid167" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>168 : Croup Associated With SARS-CoV-2: Pediatric Laryngotracheitis During the Omicron Surge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35551925" id="rid168" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>169 : Croup during the Coronavirus Disease 2019 Omicron Variant Surge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32222988" id="rid169" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>170 : Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33072647" id="rid170" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>171 : Diarrhea as a Presenting Symptom of Coronavirus Disease 2019 in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34117195" id="rid171" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>172 : Gastrointestinal Perspective of Coronavirus Disease 2019 in Children-An Updated Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32187458" id="rid172" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>173 : SARS-CoV-2 Infection in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32134205" id="rid173" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>174 : Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32118389" id="rid174" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>175 : [Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32710910" id="rid175" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>176 : Presentation of Severe Acute Respiratory Syndrome-Coronavirus 2 Infection as Cholestatic Jaundice in Two Healthy Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33075134" id="rid176" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>177 : Pancreatitis in Pediatric Patients With COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33710983" id="rid177" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>178 : Acute Pancreatitis in a Teenager With SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33591076" id="rid178" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>179 : SARS-CoV-2 Infection May Present as Acute Hepatitis in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33591076" id="rid179" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>180 : SARS-CoV-2 Infection May Present as Acute Hepatitis in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35426362" id="rid180" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>181 : Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35149651" id="rid181" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>182 : Severe Hepatitis in Pediatric Coronavirus Disease 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36476536" id="rid182" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>183 : Frequency of SARS-CoV-2 Positivity Among Children Presenting With Gastroenteritis in Emergency Department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35949041" id="rid183" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>184 : COVID-19 and Acute Neurologic Complications in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35066369" id="rid184" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>185 : Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33666649" id="rid185" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>186 : Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36342679" id="rid186" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>187 : Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37441883" id="rid187" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>188 : Neurological Manifestations of Coronavirus Disease 2019 and Mpox in Pediatric Patients and Their Management: A State-of-the-Art Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35984115" id="rid188" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>189 : Change in Seizure Incidence in Febrile Children With COVID-19 in the Era of Omicron Variant of Concern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32356945" id="rid189" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>190 : Children with Covid-19 in Pediatric Emergency Departments in Italy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32348545" id="rid190" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>191 : Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32215952" id="rid191" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>192 : Cutaneous manifestations in COVID-19: a first perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32283229" id="rid192" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>193 : A dermatologic manifestation of COVID-19: Transient livedo reticularis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33098844" id="rid193" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>194 : Giant Urticaria and Acral Peeling in a Child with Coronavirus Disease 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32845280" id="rid194" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>195 : Ocular Manifestations and Clinical Characteristics of Children With Laboratory-Confirmed COVID-19 in Wuhan, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32621881" id="rid195" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>196 : Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32730815" id="rid196" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>197 : Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33847300" id="rid197" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>198 : Pericarditis as the Main Clinical Manifestation of COVID-19 in Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32579957" id="rid198" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>199 : SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33847301" id="rid199" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>200 : Pulmonary Embolism as the Initial Presentation of Coronavirus Disease 2019 in Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33785517" id="rid200" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>201 : COVID-19-Associated Pulmonary Embolism in Pediatric Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34035074" id="rid201" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>202 : ST-Elevation Myocardial Infarction due to Acute Thrombosis in an Adolescent With COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34473684" id="rid202" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>203 : Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35472149" id="rid203" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>204 : Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32553126" id="rid204" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>205 : Renal dysfunction in hospitalised children with COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32910943" id="rid205" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>206 : Community-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Young Infants: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35061093" id="rid206" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>207 : Epidemiologic and clinical characteristics of neonates with late-onset COVID-19: 1-year data of Turkish Neonatal Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32384398" id="rid207" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>208 : COVID-19 in Neonates and Infants: Progression and Recovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36001553" id="rid208" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>209 : Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33045235" id="rid209" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>210 : Comparison of Clinical and Epidemiologic Characteristics of Young Febrile Infants with and without Severe Acute Respiratory Syndrome Coronavirus-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33606120" id="rid210" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>211 : Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34193619" id="rid211" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>212 : SARS-CoV-2 Among Infants&lt;90 Days of Age Admitted for Serious Bacterial Infection Evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35322271" id="rid212" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>213 : Intussusception and COVID-19 in Infants: Evidence for an Etiopathologic Correlation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32779885" id="rid213" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>214 : Delayed acute bronchiolitis in infants hospitalized for COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32886863" id="rid214" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>215 : Can SARS-CoV-2 cause life-threatening bronchiolitis in infants?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35389947" id="rid215" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>216 : Among Young Infants With Uncomplicated COVID-19: Should We Broaden Diagnostic Tests for Infectious Causes of Apnea?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32525645" id="rid216" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>217 : Comparison of the Clinical Features of SARS-CoV-2, Other Coronavirus and Influenza Infections in Infants Less Than 1-Year-Old.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33625505" id="rid217" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>218 : Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35996224" id="rid218" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>219 : Epidemiology of Neonatal COVID-19 in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35237826" id="rid219" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>220 : Hyperglycemia and Cytopenias as Signs of SARS-CoV-2 Delta Variant Infection in Preterm Infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33226415" id="rid220" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>221 : Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35133437" id="rid221" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>222 : Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33105340" id="rid222" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>223 : COVID-19 Gastrointestinal Manifestations Are Independent Predictors of PICU Admission in Hospitalized Pediatric Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33197493" id="rid223" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>224 : Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33753892" id="rid224" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>225 : Risk profiles of severe illness in children with COVID-19: a meta-analysis of individual patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34358472" id="rid225" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>226 : Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32329974" id="rid226" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>227 : Mild or Moderate Covid-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32329974" id="rid227" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>228 : Mild or Moderate Covid-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32329974" id="rid228" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>229 : Mild or Moderate Covid-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32329974" id="rid229" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>230 : Mild or Moderate Covid-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34870392" id="rid230" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>231 : How Common is Long COVID in Children and Adolescents?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36107254" id="rid231" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>232 : Prevalence and clinical presentation of long COVID in children: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35765138" id="rid232" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>233 : Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34210789" id="rid233" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>234 : Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35867061" id="rid234" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>235 : Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36201673" id="rid235" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>236 : SARS-CoV-2 Sequelae and Postdischarge Health Care Visits Over 5 Months Follow-up Among Children Hospitalized for COVID-19 or MIS-C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37466944" id="rid236" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>237 : Incidence and Characteristics in Children with Post-COVID-19 Condition in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35994282" id="rid237" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>238 : Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35213866" id="rid238" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>239 : The Challenge of Studying Long COVID: An Updated Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35058281" id="rid239" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>240 : Long covid in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35939608" id="rid240" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>241 : Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34264266" id="rid241" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>242 : Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34534416" id="rid242" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>243 : Protracted respiratory findings in children post-SARS-CoV-2 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35143770" id="rid243" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>244 : Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35000003" id="rid244" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>245 : Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35925799" id="rid245" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>246 : Post-COVID-19 Symptoms and Conditions Among Children and Adolescents - United States, March 1, 2020-January 31, 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35987197" id="rid246" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>247 : Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36355754" id="rid247" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>248 : Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36125379" id="rid248" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>249 : Pulmonary Dysfunction after Pediatric COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37476923" id="rid249" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>250 : A Systematic Review of Persistent Clinical Features After SARS-CoV-2 in the Pediatric Population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35642018" id="rid250" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>251 : Ongoing Dizziness Following Acute COVID-19 Infection: A Single Center Pediatric Case Series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36166227" id="rid251" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>252 : Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36504922" id="rid252" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>253 : Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35960522" id="rid253" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>254 : Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32146694" id="rid254" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>255 : Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32179910" id="rid255" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>256 : Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32556807" id="rid256" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>257 : Coronavirus disease 2019 (COVID-19) in children: a systematic review of imaging findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32926572" id="rid257" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>258 : Pediatric lung imaging features of COVID-19: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33404786" id="rid258" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>259 : Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32317309" id="rid259" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>260 : Lung Ultrasound in Children With COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33234533" id="rid260" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>261 : Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32710743" id="rid261" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>262 : Systematic Severe Acute Respiratory Syndrome Coronavirus 2 Screening at Hospital Admission in Children: A French Prospective Multicenter Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32770233" id="rid262" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>263 : Coronavirus Disease 2019 (COVID-19) and Children: Adding Another Piece to the Puzzle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32766824" id="rid263" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>264 : A Pediatric Infectious Disease Perspective on COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33264212" id="rid264" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>265 : Pneumonia in Hospitalized Children During SARS-CoV-2 Pandemic. Is it All COVID-19? Comparison Between COVID and Non-COVID Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33537361" id="rid265" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>266 : Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35593186" id="rid266" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>267 : Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35593186" id="rid267" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>268 : Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35593186" id="rid268" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>269 : Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35593186" id="rid269" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>270 : Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36539917" id="rid270" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>271 : Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35042748" id="rid271" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>272 : Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34050951" id="rid272" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>273 : European multicenter evaluation of Xpert®Xpress SARS-CoV-2/Flu/RSV test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34986156" id="rid273" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>274 : Analytical performances of the AMPLIQUICK®Respiratory Triplex assay for simultaneous detection and differentiation of SARS-CoV-2, influenza A/B and respiratory syncytial viruses in respiratory specimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34839127" id="rid274" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>275 : Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34592335" id="rid275" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>276 : Comparison of the PowerChek SARS-CoV-2, Influenza A&amp;B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34592335" id="rid276" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>277 : Comparison of the PowerChek SARS-CoV-2, Influenza A&amp;B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32897374" id="rid277" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>278 : Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36520656" id="rid278" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>279 : Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged&lt;18 Years Who Were Hospitalized or Died with Influenza - United States, 2021-22 Influenza Season.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36520656" id="rid279" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>280 : Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged&lt;18 Years Who Were Hospitalized or Died with Influenza - United States, 2021-22 Influenza Season.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32320003" id="rid280" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>281 : Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32160148" id="rid281" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>282 : Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32196707" id="rid282" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>283 : The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32267826" id="rid283" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>284 : Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32293646" id="rid284" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>285 : Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33464015" id="rid285" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>286 : SARS-CoV-2 and Respiratory Syncytial Virus Coinfection in Hospitalized Pediatric Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32621013" id="rid286" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>287 : Management strategies for children with COVID-19: ESPR practical recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32749530" id="rid287" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>288 : Thoracic imaging of coronavirus disease 2019 (COVID-19) in children: a series of 91 cases.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
